ACUTE_MYELOID_LEUKEMIA_[DOID:9119]  0
ALS  8
C9-ALS_FTD	MMI	19.40	Frontotemporal dementia	C0338451	[dsyn]	["FTD"-tx-1-"FTD"-noun-0]	TX	7/3	C10.228.140.380.266.299;C10.574.950.300.299;C18.452.845.800.300.299;F03.615.400.380.299
C9-ALS_FTD	MMI	3.48	AKR1C1 wt Allele	C3540507	[gngm]	["C9"-tx-1-"C9"-noun-0]	TX	0/2	
C9-ALS_FTD	MMI	3.48	C9 gene	C1413029	[gngm]	["C9"-tx-1-"C9"-noun-0]	TX	0/2	
FTDALS1	MMI	5.18	AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	C1862937	[dsyn]	["FTDALS1"-tx-1-"FTDALS1"-noun-0]	TX	0/7	
SALS	MMI	16.44	Sodium Chloride	C0037494	[bacs,inch,phsu]	["Salt"-tx-1-"SALS"-noun-0]	TX	0/4	D01.210.450.150.875;D01.857.650
SALS	MMI	13.28	Sodium Chloride, Dietary	C0206136	[food]	["Salt"-tx-1-"SALS"-noun-0]	TX	0/4	D01.857.650.705;D01.857.700.705
SALS	MMI	6.97	Salts	C0036140	[chvs]	["Salts"-tx-1-"SALS"-noun-0]	TX	0/4	D01.786
THYROID	MMI	5.18	THYROID DIAGNOSTIC RADIOPHARMACEUTICALS	C3540038	[irda]	["THYROID"-tx-1-"THYROID"-noun-0]	TX	0/7	
ATTRIBUTEENTRY  0
AUTISM_SPECTRUM_DISORDER  2
AUTISM_SPECTRUM_DISORDER	MMI	14.64	Autism Spectrum Disorders	C1510586	[mobd]	["AUTISM SPECTRUM DISORDER"-tx-1-"AUTISM SPECTRUM DISORDER"-noun-0]	TX	0/24	F03.625.164.113
AUTISM_SPECTRUM_DISORDER	MMI	5.18	Pervasive Development Disorder	C0524528	[mobd]	["Autism spectrum disorder"-tx-1-"AUTISM SPECTRUM DISORDER"-noun-0]	TX	0/24	
BREAST  19
ADENOMYOEPITHELIOMA_OF_THE_BREAST	MMI	5.18	Breast Adenomyoepithelioma	C1510795	[neop]	["Adenomyoepithelioma of the Breast"-tx-1-"ADENOMYOEPITHELIOMA OF THE BREAST"-noun-0]	TX	0/33	
BREAST_ADENOCARCINOMA	MMI	5.18	breast adenocarcinoma	C0858252	[neop]	["Breast Adenocarcinoma"-tx-1-"BREAST ADENOCARCINOMA"-noun-0]	TX	0/21	
BREAST	MMI	8.34	Breast	C0006141	[bpoc]	["BREAST"-tx-1-"BREAST"-noun-0]	TX	0/6	A01.236
BREAST	MMI	5.18	Entire breast	C1268990	[bpoc]	["Breast"-tx-1-"BREAST"-noun-0]	TX	0/6	
BREAST_CANCER	MMI	14.64	Breast Carcinoma	C0678222	[neop]	["Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	0/13	C04.588.180;C17.800.090.500
BREAST_CANCER	MMI	5.18	Malignant neoplasm of breast	C0006142	[neop]	["-- Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	0/13	
BREAST_CARCINOMA	MMI	14.64	Breast Carcinoma	C0678222	[neop]	["BREAST CARCINOMA"-tx-1-"BREAST CARCINOMA"-noun-0]	TX	0/16	C04.588.180;C17.800.090.500
BREAST_CARCINOMA	MMI	5.18	Malignant neoplasm of breast	C0006142	[neop]	["Breast Carcinoma"-tx-1-"BREAST CARCINOMA"-noun-0]	TX	0/16	
BREAST_DUCTAL_CARCINOMA	MMI	24.11	Mammary Ductal Carcinoma	C0021367	[neop]	["breast ductal carcinoma"-tx-1-"BREAST DUCTAL CARCINOMA"-noun-0]	TX	0/23	C04.557.470.200.025.232.500;C04.557.470.615.132.500;C04.588.180.390;C17.800.090.500.390
LUMINAL_BREAST_CANCER	MMI	13.22	Breast Carcinoma	C0678222	[neop]	["Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	8/13	C04.588.180;C17.800.090.500
LUMINAL_BREAST_CANCER	MMI	3.75	Malignant neoplasm of breast	C0006142	[neop]	["-- Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	8/13	
LUMINAL_BREAST_CANCER	MMI	3.48	Luminal region	C0524462	[spco]	["Luminal"-tx-1-"LUMINAL"-adj-0]	TX	0/7	
PDX_BREAST_CANCER	MMI	13.22	Breast Carcinoma	C0678222	[neop]	["Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	4/13	C04.588.180;C17.800.090.500
PDX_BREAST_CANCER	MMI	12.94	10-propargyl-10-deazaaminopterin	C0879404	[orch,phsu]	["PDX"-tx-1-"PDX"-noun-0]	TX	0/3	x.x.x.x
PDX_BREAST_CANCER	MMI	3.75	Malignant neoplasm of breast	C0006142	[neop]	["-- Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	4/13	
PDX_BREAST_CANCER	MMI	3.48	Patient Derived Xenograft	C4050317	[emod]	["PDX"-tx-1-"PDX"-noun-0]	TX	0/3	
PDX_BREAST_CANCER	MMI	3.48	Preliminary diagnosis qualifier value	C0332134	[qlco]	["PDX"-tx-1-"PDX"-noun-0]	TX	0/3	
TRIPLE-NEGATIVE_BREAST_CANCER	MMI	17.80	Triple Negative Breast Neoplasms	C3539878	[neop]	["Triple-Negative Breast Cancer"-tx-1-"TRIPLE-NEGATIVE BREAST CANCER"-noun-0]	TX	0/29	C04.588.180.788;C17.800.090.500.788
TRIPLE-NEGATIVE_BREAST_CANCER	MMI	5.18	Triple-Negative Breast Cancer Finding	C2348819	[fndg]	["triple-negative breast cancer"-tx-1-"TRIPLE-NEGATIVE BREAST CANCER"-noun-0]	TX	0/29	
C9ALS  0
CF  5
CF	MMI	17.80	Congo	C0009738	[geoa]	["CF"-tx-1-"CF"-noun-0]	TX	0/2	Z01.058.290.100.140
CF	MMI	5.18	CFTR wt Allele	C3811819	[gngm]	["CF"-tx-1-"CF"-noun-0]	TX	0/2	
NON-CF	MMI	16.30	Congo	C0009738	[geoa]	["CF"-tx-1-"CF"-adj-0]	TX	4/2	Z01.058.290.100.140
NON-CF	MMI	3.68	CFTR wt Allele	C3811819	[gngm]	["CF"-tx-1-"CF"-adj-0]	TX	4/2	
NON-CF	MMI	3.68	Negation	C1518422	[ftcn]	["Non"-tx-1-"NON"-adj-0]	TX	0/3	
CIS  1
CIS	MMI	5.18	Genus Cis	C1504308	[euka]	["Cis"-tx-1-"CIS"-adj-0]	TX	0/3	
COLON  19
COLON	MMI	17.80	Colon structure (body structure)	C0009368	[bpoc]	["COLON"-tx-1-"COLON"-noun-0]	TX	0/5	A03.556.124.526.356;A03.556.249.249.356
COLON	MMI	5.18	Colon <insect>	C3888384	[euka]	["Colon"-tx-1-"COLON"-noun-0]	TX	0/5	
COLON	MMI	5.18	Entire colon	C1281569	[bpoc]	["Colon"-tx-1-"COLON"-noun-0]	TX	0/5	
COLON_CANCER	MMI	5.18	Colon Carcinoma	C0699790	[neop]	["COLON CANCER"-tx-1-"COLON CANCER"-noun-0]	TX	0/12	
COLON_CANCER	MMI	5.18	Malignant tumor of colon	C0007102	[neop]	["-- Colon Cancer"-tx-1-"COLON CANCER"-noun-0]	TX	0/12	
COLON_CARCINOMA,_HNPCC	MMI	12.94	MLH1 protein, human	C0252642	[aapp,bacs]	["HNPCC"-tx-1-"HNPCC"-noun-0]	TX	17/5	x.x.x.x
COLON_CARCINOMA,_HNPCC	MMI	3.75	Colon Carcinoma	C0699790	[neop]	["COLON CARCINOMA"-tx-1-"COLON CARCINOMA"-noun-0]	TX	0/15	
COLON_CARCINOMA,_PRIMARY	MMI	16.09	Colon structure (body structure)	C0009368	[bpoc]	["COLON"-tx-1-"COLON"-noun-0]	TX	0/5	A03.556.124.526.356;A03.556.249.249.356
COLON_CARCINOMA,_PRIMARY	MMI	3.78	Primary Carcinoma	C1335475	[neop]	["Primary Carcinoma"-tx-1-"CARCINOMA PRIMARY"-noun-0]	TX	6/9,17/7	
COLON_CARCINOMA,_PRIMARY	MMI	3.75	Colon Carcinoma	C0699790	[neop]	["COLON CARCINOMA"-tx-1-"COLON CARCINOMA"-noun-0]	TX	0/15	
COLON_CARCINOMA,_PRIMARY	MMI	3.48	Colon <insect>	C3888384	[euka]	["Colon"-tx-1-"COLON"-noun-0]	TX	0/5	
COLON_CARCINOMA,_PRIMARY	MMI	3.48	Entire colon	C1281569	[bpoc]	["Colon"-tx-1-"COLON"-noun-0]	TX	0/5	
COLON_CARCINOMA,_PRIMARY	MMI	3.48	Primary	C0205225	[qlco]	["Primary"-tx-1-"PRIMARY"-adj-0]	TX	17/7	
COLON_CARCINOMA,_PRIMARY	MMI	3.48	Primary operation	C0439631	[topp]	["Primary"-tx-1-"PRIMARY"-adj-0]	TX	17/7	
COLON_CARCINOMA,_PRIMARY	MMI	3.48	True primary (qualifier value)	C0439612	[tmco]	["Primary"-tx-1-"PRIMARY"-adj-0]	TX	17/7	
COLON_CARCINOMA,_SPORADIC	MMI	3.75	Colon Carcinoma	C0699790	[neop]	["COLON CARCINOMA"-tx-1-"COLON CARCINOMA"-noun-0]	TX	0/15	
COLON_CARCINOMA,_SPORADIC	MMI	3.48	Isolated cases	C1853237	[fndg]	["Sporadic"-tx-1-"SPORADIC"-adj-0]	TX	17/8	
COLON_CARCINOMA,_SPORADIC	MMI	3.48	Sporadic (qualifier value)	C0205422	[tmco]	["Sporadic"-tx-1-"SPORADIC"-adj-0]	TX	17/8	
COLON_CARCINOMA	MMI	5.18	Colon Carcinoma	C0699790	[neop]	["COLON CARCINOMA"-tx-1-"COLON CARCINOMA"-noun-0]	TX	0/15	
COLORECTAL_CANCER  4
COLORECTAL_CANCER	MMI	20.95	Colorectal Cancer	C1527249	[neop]	["Colorectal Cancer"-tx-1-"COLORECTAL CANCER"-noun-0]	TX	0/17	C04.588.274.476.411.307;C06.301.371.411.307;C06.405.249.411.307;C06.405.469.158.356;C06.405.469.491.307;C06.405.469.860.180
COLORECTAL_CANCER	MMI	20.95	Colorectal Carcinoma	C0009402	[neop]	["Colorectal Cancer"-tx-1-"COLORECTAL CANCER"-noun-0]	TX	0/17	C04.588.274.476.411.307;C06.301.371.411.307;C06.405.249.411.307;C06.405.469.158.356;C06.405.469.491.307;C06.405.469.860.180
COLORECTAL_CANCER	MMI	5.18	Colorectal Cancer Pathway	C2984278	[cnce]	["Colorectal cancer"-tx-1-"COLORECTAL CANCER"-noun-0]	TX	0/17	
COLORECTAL_CANCER	MMI	5.18	NCI CTEP SDC Colorectal Cancer Sub-Category Terminology	C3542412	[inpr]	["Colorectal Cancer"-tx-1-"COLORECTAL CANCER"-noun-0]	TX	0/17	
CONTROL  19
CONTROL_(CO)	AA	CO	CONTROL	1	2	1	7	9:2
CONTROL_(CO)	MMI	5.18	Control function	C2587213	[ftcn]	["Control"-tx-1-"CONTROL"-noun-0]	TX	0/7	
CONTROL_(CO)	MMI	5.18	Scientific Control	C1882979	[cnce]	["Control"-tx-1-"CONTROL"-noun-0]	TX	0/7	
CONTROL_(CO)	MMI	5.18	True Control Status	C3274648	[qlco]	["Control"-tx-1-"CONTROL"-noun-0]	TX	0/7	
CONTROL_(CO)	MMI	5.18	control aspects	C0243148	[qlco]	["control"-tx-1-"CONTROL"-noun-0]	TX	0/7	
CONTROL_(CO)	MMI	5.18	control substance	C1550141	[sbst]	["Control"-tx-1-"CONTROL"-noun-0]	TX	0/7	
CONTROL	MMI	5.18	Control function	C2587213	[ftcn]	["Control"-tx-1-"CONTROL"-noun-0]	TX	0/7	
CONTROL	MMI	5.18	Scientific Control	C1882979	[cnce]	["Control"-tx-1-"CONTROL"-noun-0]	TX	0/7	
CONTROL	MMI	5.18	True Control Status	C3274648	[qlco]	["Control"-tx-1-"CONTROL"-noun-0]	TX	0/7	
CONTROL	MMI	5.18	control aspects	C0243148	[qlco]	["control"-tx-1-"CONTROL"-noun-0]	TX	0/7	
CONTROL	MMI	5.18	control substance	C1550141	[sbst]	["Control"-tx-1-"CONTROL"-noun-0]	TX	0/7	
HEALTHY_CONTROL	MMI	5.18	Healthy Control	C2986479	[qlco]	["Healthy Control"-tx-1-"HEALTHY CONTROL"-noun-0]	TX	0/15	
NONE_(HEALTHY_CONTROL)	MMI	3.75	Healthy Control	C2986479	[qlco]	["Healthy Control"-tx-1-"HEALTHY CONTROL"-noun-0]	TX	6/15	
WILD-TYPE_CONTROL	MMI	3.63	Control function	C2587213	[ftcn]	["Control"-tx-1-"CONTROL"-noun-0]	TX	10/7	
WILD-TYPE_CONTROL	MMI	3.63	Scientific Control	C1882979	[cnce]	["Control"-tx-1-"CONTROL"-noun-0]	TX	10/7	
WILD-TYPE_CONTROL	MMI	3.63	True Control Status	C3274648	[qlco]	["Control"-tx-1-"CONTROL"-noun-0]	TX	10/7	
WILD-TYPE_CONTROL	MMI	3.63	control aspects	C0243148	[qlco]	["control"-tx-1-"CONTROL"-noun-0]	TX	10/7	
WILD-TYPE_CONTROL	MMI	3.63	control substance	C1550141	[sbst]	["Control"-tx-1-"CONTROL"-noun-0]	TX	10/7	
WILD-TYPE_CONTROL	MMI	3.53	Wild Type	C1883559	[gngm]	["Wildtype"-tx-1-"WILD-TYPE"-adj-0]	TX	0/9	
CTL  1
CTL	MMI	30.42	Cytotoxic T-Lymphocytes	C0039195	[cell]	["CTL"-tx-1-"CTL"-noun-0]	TX	0/3	A11.118.637.555.283.875;A11.118.637.555.567.550.500.200;A11.118.637.555.567.569.220.200;A11.118.637.555.567.569.500.200;A15.145.229.637.555.283.875;A15.145.229.637.555.567.550.500.200;A15.145.229.637.555.567.569.220.200;A15.145.229.637.555.567.569.500.200;A15.382.490.555.283.875;A15.382.490.555.567.550.500.200;A15.382.490.555.567.569.220.200;A15.382.490.555.567.569.500.200
DM2  0
DOID:0050745  0
DOID:0050925  0
DOID:1339  0
DOID:3008  0
DOID:5419_SCHIZOPHRENIA  0
GBM  0
GCTB  0
GLIOLBASTOMA  0
H  258
ACUTE_LYMPHOBLASTIC_LEUKAEMIA	MMI	17.80	Precursor Cell Lymphoblastic Leukemia Lymphoma	C1961102	[neop]	["Acute Lymphoblastic Leukemia"-tx-1-"ACUTE LYMPHOBLASTIC LEUKAEMIA"-noun-0]	TX	0/29	C04.557.337.428.600;C15.604.515.560.600;C20.683.515.528.600
ACUTE_LYMPHOBLASTIC_LEUKAEMIA	MMI	5.18	Acute lymphocytic leukemia	C0023449	[neop]	["Acute lymphoblastic leukaemia"-tx-1-"ACUTE LYMPHOBLASTIC LEUKAEMIA"-noun-0]	TX	0/29	
ACUTE_LYMPHOBLASTIC_LEUKAEMIA	MMI	5.18	NCI CTEP SDC Acute Lymphoblastic Leukemia Sub-Category Terminology	C3542401	[inpr]	["Acute Lymphoblastic Leukemia"-tx-1-"ACUTE LYMPHOBLASTIC LEUKAEMIA"-noun-0]	TX	0/29	
ACUTE_LYMPHOBLASTIC_LEUKEMIA	MMI	17.80	Precursor Cell Lymphoblastic Leukemia Lymphoma	C1961102	[neop]	["Acute Lymphoblastic Leukemia"-tx-1-"ACUTE LYMPHOBLASTIC LEUKEMIA"-noun-0]	TX	0/28	C04.557.337.428.600;C15.604.515.560.600;C20.683.515.528.600
ACUTE_LYMPHOBLASTIC_LEUKEMIA	MMI	5.18	Acute lymphocytic leukemia	C0023449	[neop]	["Acute lymphoblastic leukaemia"-tx-1-"ACUTE LYMPHOBLASTIC LEUKEMIA"-noun-0]	TX	0/28	
ACUTE_LYMPHOBLASTIC_LEUKEMIA	MMI	5.18	NCI CTEP SDC Acute Lymphoblastic Leukemia Sub-Category Terminology	C3542401	[inpr]	["Acute Lymphoblastic Leukemia"-tx-1-"ACUTE LYMPHOBLASTIC LEUKEMIA"-noun-0]	TX	0/28	
ACUTE_PHLEGMONOUS_APPENDICITIS	MMI	16.40	Appendicitis	C0003615	[dsyn]	["Acute Appendicitis"-tx-1-"ACUTE APPENDICITIS"-noun-0]	TX	0/5,18/12	C01.539.463.099;C06.405.205.099;C06.405.469.110.207
ACUTE_PHLEGMONOUS_APPENDICITIS	MMI	3.78	Acute appendicitis NOS (disorder)	C0085693	[dsyn]	["APPENDICITIS, ACUTE"-tx-1-"ACUTE APPENDICITIS"-noun-0]	TX	0/5,18/12	
ACUTE_PHLEGMONOUS_APPENDICITIS	MMI	3.48	Phlegmonous	C0443278	[ftcn]	["Phlegmonous"-tx-1-"PHLEGMONOUS"-adj-0]	TX	6/11	
ADAMANTINOMATOUS_CRANIOPHARYNGIOMA	MMI	17.80	Adamantinous Craniopharyngioma	C0431129	[neop]	["Adamantinomatous Craniopharyngioma"-tx-1-"ADAMANTINOMATOUS CRANIOPHARYNGIOMA"-noun-0]	TX	0/34	C04.557.465.625.200;C04.557.580.625.200
ADENOMYOEPITHELIOMA_OF_THE_BREAST	MMI	5.18	Breast Adenomyoepithelioma	C1510795	[neop]	["Adenomyoepithelioma of the Breast"-tx-1-"ADENOMYOEPITHELIOMA OF THE BREAST"-noun-0]	TX	0/33	
ADHD	MMI	14.64	Attention deficit hyperactivity disorder	C1263846	[mobd]	["ADHD"-tx-1-"ADHD"-noun-0]	TX	0/4	F03.625.094.150
ALZHEIMER'S_DISEASE	MMI	16.40	Alzheimer's Disease	C0002395	[dsyn]	["ALZHEIMER DISEASE"-tx-1-"ALZHEIMER DISEASE"-noun-0]	TX	0/9,12/7	C10.228.140.380.100;C10.574.945.249;F03.615.400.100
ALZHEIMER'S_DISEASE	MMI	3.78	Alzheimer's Disease Pathway KEGG	C1521724	[patf]	["Alzheimer's Disease"-tx-1-"ALZHEIMER DISEASE"-noun-0]	TX	0/9,12/7	
AML_WITH_INV(3)(Q21Q26.2)_RPN1-EVI1	MMI	16.21	Leukemia, Myelocytic, Acute	C0023467	[neop]	["AML"-tx-1-"AML"-noun-0]	TX	0/3	C04.557.337.539.275
AML_WITH_INV(3)(Q21Q26.2)_RPN1-EVI1	MMI	16.07	Chromosome inversion	C0021943	[comd]	["inv"-tx-1-"INV"-adj-0]	TX	9/3	C23.550.210.190;G05.355.600.805.500;G05.365.590.175.190;G05.365.590.770.500
AML_WITH_INV(3)(Q21Q26.2)_RPN1-EVI1	MMI	3.45	Evi-1 protein	C0082512	[aapp,bacs]	["EVI-1"-tx-1-"EVI1"-noun-0]	TX	31/4	
AML_WITH_INV(3)(Q21Q26.2)_RPN1-EVI1	MMI	3.45	INVS gene	C1425144	[gngm]	["INV"-tx-1-"INV"-adj-0]	TX	9/3	
AML_WITH_INV(3)(Q21Q26.2)_RPN1-EVI1	MMI	3.45	PSMD2 gene	C1419032	[gngm]	["Rpn1"-tx-1-"RPN1"-noun-0]	TX	26/4	
AML_WITH_INV(3)(Q21Q26.2)_RPN1-EVI1	MMI	3.45	RPN1 gene	C1419697	[gngm]	["RPN1"-tx-1-"RPN1"-noun-0]	TX	26/4	
AML_WITH_INV(3)(Q21Q26.2)_RPN1-EVI1	MMI	3.45	ribophorin I	C0140512	[aapp,enzy,rcpt]	["RPN1"-tx-1-"RPN1"-noun-0]	TX	26/4	
AML_WITH_MDS-RELATED_CHANGES	MMI	3.67	Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome	C1332153	[neop]	["AML/MDS"-tx-1-"AML MDS"-noun-0]	TX	0/3,9/3	
AML_WITH_MDS-RELATED_CHANGES	MMI	3.46	Changed status	C0443172	[qnco]	["changes"-tx-1-"CHANGES"-noun-0]	TX	21/7	
AML_WITH_MDS-RELATED_CHANGES	MMI	3.46	Changing	C0392747	[ftcn]	["changes"-tx-1-"CHANGES"-noun-0]	TX	21/7	
AML_WITH_MDS-RELATED_CHANGES	MMI	3.46	Related personal status	C0445223	[fndg]	["Related"-tx-1-"RELATED"-adj-0]	TX	13/7	
AML_WITH_MDS-RELATED_CHANGES	MMI	3.46	Relationships	C0439849	[qlco]	["Related"-tx-1-"RELATED"-adj-0]	TX	13/7	
AML_WITH_RECURRENT_GENE_MUTATIONS	MMI	3.81	Acute Myeloid Leukemia with Gene Mutations	C2826176	[neop]	["AML with Gene Mutations"-tx-1-"AML WITH GENE MUTATIONS"-noun-0]	TX	0/8,19/14	
AML_WITH_RECURRENT_GENE_MUTATIONS	MMI	3.46	Recurrent	C2945760	[tmco]	["RECURRENT"-tx-1-"RECURRENT"-adj-0]	TX	9/9	
ANAPLASTIC_THYROID_CANCER	MMI	17.80	Anaplastic thyroid carcinoma	C0238461	[neop]	["Anaplastic Thyroid Cancer"-tx-1-"ANAPLASTIC THYROID CANCER"-noun-0]	TX	0/25	C04.557.470.200.725
ARTHRALGIA	MMI	20.95	Arthralgia	C0003862	[sosy]	["ARTHRALGIA"-tx-1-"ARTHRALGIA"-noun-0]	TX	0/10	C05.550.091;C10.597.617.133;C23.888.592.612.094;F02.830.816.444.350;G11.561.600.810.444.350
AUTOIMMUNE_HEPATITIS	MMI	17.80	Hepatitis, Autoimmune	C0241910	[dsyn]	["Autoimmune Hepatitis"-tx-1-"AUTOIMMUNE HEPATITIS"-noun-0]	TX	0/20	C06.552.380.350.050;C20.111.567
AUTOINFLAMMATORY_SYNDROME_WITH_IMMUNE_DEFICIENCY	MMI	6.64	Immunologic Deficiency Syndromes	C0021051	[dsyn]	["Immune deficiency"-tx-1-"IMMUNE DEFICIENCY"-noun-0]	TX	31/17	C20.673
AUTOINFLAMMATORY_SYNDROME_WITH_IMMUNE_DEFICIENCY	MMI	3.65	Autoinflammatory Syndrome	C3890737	[dsyn]	["Autoinflammatory Syndrome"-tx-1-"AUTOINFLAMMATORY SYNDROME"-noun-0]	TX	0/25	
B-ALL_WITH_T(12;21)_TEL-AML1_(ETV6-RUNX1)	MMI	22.53	Burkitt Lymphoma	C0006413	[neop]	["b-all"-tx-1-"B-ALL"-noun-0]	TX	0/5	C02.256.466.313.165;C02.928.313.165;C04.557.386.480.150.165;C15.604.515.569.480.150.165;C20.683.515.761.480.150.165
B-ALL_WITH_T(12;21)_TEL-AML1_(ETV6-RUNX1)	MMI	12.92	TEL-AML1 fusion protein	C0531832	[aapp,bacs]	["TEL-AML1"-tx-1-"TEL-AML1"-noun-0]	TX	20/8	x.x.x.x
B-ALL_WITH_T(12;21)_TEL-AML1_(ETV6-RUNX1)	MMI	3.60	Precursor B-cell lymphoblastic leukemia	C1292769	[neop]	["B-ALL"-tx-1-"B-ALL"-noun-0]	TX	0/5	
B-ALL_WITH_T(9;22)_BCR-ABL	MMI	28.70	Fusion Proteins, bcr-abl	C0004891	[aapp,bacs]	["BCR/ABL"-tx-1-"BCR-ABL"-noun-0]	TX	19/7	D08.811.913.696.620.682.725.500.500;D12.776.602.500.500.100;D12.776.624.664.500.100;D12.776.624.664.700.171.500
B-ALL_WITH_T(9;22)_BCR-ABL	MMI	22.54	Burkitt Lymphoma	C0006413	[neop]	["b-all"-tx-1-"B-ALL"-noun-0]	TX	0/5	C02.256.466.313.165;C02.928.313.165;C04.557.386.480.150.165;C15.604.515.569.480.150.165;C20.683.515.761.480.150.165
B-ALL_WITH_T(9;22)_BCR-ABL	MMI	3.61	Precursor B-cell lymphoblastic leukemia	C1292769	[neop]	["B-ALL"-tx-1-"B-ALL"-noun-0]	TX	0/5	
B-ALL_WITH_T(9;22)_BCR-ABL	MMI	3.47	BCR-ABL Fusion Gene	C1835417	[gngm]	["BCR-ABL"-tx-1-"BCR-ABL"-noun-0]	TX	19/7	
B-CELL_LYMPHOMA,_UNCLASSIFIABLE,_WITH_FEATURES_INTERMEDIATE_BETWEEN_DLBCL_AND_BL	MMI	22.37	Burkitt Lymphoma	C0006413	[neop]	["BL"-tx-1-"BL"-noun-0]	TX	78/2	C02.256.466.313.165;C02.928.313.165;C04.557.386.480.150.165;C15.604.515.569.480.150.165;C20.683.515.761.480.150.165
B-CELL_LYMPHOMA,_UNCLASSIFIABLE,_WITH_FEATURES_INTERMEDIATE_BETWEEN_DLBCL_AND_BL	MMI	22.37	Diffuse Large B-Cell Lymphoma	C0079744	[neop]	["DLBCL"-tx-1-"DLBCL"-noun-0]	TX	68/5	C04.557.386.480.150.585;C15.604.515.569.480.150.585;C20.683.515.761.480.150.585
B-CELL_LYMPHOMA,_UNCLASSIFIABLE,_WITH_FEATURES_INTERMEDIATE_BETWEEN_DLBCL_AND_BL	MMI	19.39	B-Cell Lymphomas	C0079731	[neop]	["B cell lymphoma"-tx-1-"B-CELL LYMPHOMA"-noun-0]	TX	0/15	C04.557.386.480.150;C15.604.515.569.480.150;C20.683.515.761.480.150
B-CELL_LYMPHOMA,_UNCLASSIFIABLE,_WITH_FEATURES_INTERMEDIATE_BETWEEN_DLBCL_AND_BL	MMI	12.91	Bolivia	C0005918	[geoa]	["BL"-tx-1-"BL"-noun-0]	TX	78/2	Z01.107.757.136
B-CELL_LYMPHOMA,_UNCLASSIFIABLE,_WITH_FEATURES_INTERMEDIATE_BETWEEN_DLBCL_AND_BL	MMI	3.45	Antimicrobial Intermediate Susceptibility Result	C2827755	[lbtr]	["INTERMEDIATE"-tx-1-"INTERMEDIATE"-adj-0]	TX	47/12	
B-CELL_LYMPHOMA,_UNCLASSIFIABLE,_WITH_FEATURES_INTERMEDIATE_BETWEEN_DLBCL_AND_BL	MMI	3.45	Boolean	C1552663	[inpr]	["BL"-tx-1-"BL"-noun-0]	TX	78/2	
B-CELL_LYMPHOMA,_UNCLASSIFIABLE,_WITH_FEATURES_INTERMEDIATE_BETWEEN_DLBCL_AND_BL	MMI	3.45	Intermediate	C0205103	[spco]	["INTERMEDIATE"-tx-1-"INTERMEDIATE"-adj-0]	TX	47/12	
B-CELL_LYMPHOMA,_UNCLASSIFIABLE,_WITH_FEATURES_INTERMEDIATE_BETWEEN_DLBCL_AND_BL	MMI	3.45	Intermediate Mitosis-Karyorrhexis Index	C3889971	[qnco]	["Intermediate"-tx-1-"INTERMEDIATE"-adj-0]	TX	47/12	
B-CELL_LYMPHOMA,_UNCLASSIFIABLE,_WITH_FEATURES_INTERMEDIATE_BETWEEN_DLBCL_AND_BL	MMI	3.45	Observation Interpretation - intermediate	C1550465	[lbtr]	["Intermediate"-tx-1-"INTERMEDIATE"-adj-0]	TX	47/12	
B-CELL_LYMPHOMA,_UNCLASSIFIABLE,_WITH_FEATURES_INTERMEDIATE_BETWEEN_DLBCL_AND_BL	MMI	3.45	Saint Barthelemy	C2827109	[geoa]	["BL"-tx-1-"BL"-noun-0]	TX	78/2	
B-CELL_LYMPHOMA,_UNCLASSIFIABLE,_WITH_FEATURES_INTERMEDIATE_BETWEEN_DLBCL_AND_BL	MMI	3.43	Array Feature	C1706388	[cnce]	["Feature"-tx-1-"FEATURES"-noun-0]	TX	38/8	
B-CELL_LYMPHOMA,_UNCLASSIFIABLE,_WITH_FEATURES_INTERMEDIATE_BETWEEN_DLBCL_AND_BL	MMI	3.43	Characteristics	C1521970	[qlco]	["Feature"-tx-1-"FEATURES"-noun-0]	TX	38/8	
B-CELL_LYMPHOMA,_UNCLASSIFIABLE,_WITH_FEATURES_INTERMEDIATE_BETWEEN_DLBCL_AND_BL	MMI	3.43	Feature	C2348519	[qlco]	["Feature"-tx-1-"FEATURES"-noun-0]	TX	38/8	
B-CELL_LYMPHOMA,_UNCLASSIFIABLE,_WITH_FEATURES_INTERMEDIATE_BETWEEN_DLBCL_AND_BL	MMI	3.43	Image Feature	C2346469	[qlco]	["Feature"-tx-1-"FEATURES"-noun-0]	TX	38/8	
BIPHENOTYPIC_B_MYELOMONOCYTIC_LEUKEMIA	MMI	3.68	Myelomonocytic leukemia	C0027019	[neop]	["Myelomonocytic leukemia"-tx-1-"MYELOMONOCYTIC LEUKEMIA"-noun-0]	TX	15/23	
BLEPHAROSPASM	MMI	11.49	Blepharospasm	C0005747	[dsyn]	["BLEPHAROSPASM"-tx-1-"BLEPHAROSPASM"-noun-0]	TX	0/13	C11.338.250
BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	9.99	Bone Marrow Cells	C0005955	[cell]	["Bone Marrow Cells"-tx-1-"BONE MARROW CELLS"-noun-0]	TX	0/17	A11.148;A15.378.316
BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	3.76	Encounter for being a bone marrow donor	C1313934	[fndg]	["Bone marrow donors"-tx-1-"BONE MARROW DONORS"-noun-0]	TX	0/11,31/6	
BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	3.60	Cells	C0007634	[cell]	["Cells"-tx-1-"CELLS"-noun-0]	TX	12/5	A11
BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	3.60	Cells [Chemical/Ingredient]	C3282337	[cell]	["Cells"-tx-1-"CELLS"-noun-0]	TX	12/5	
BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	3.46	Donor person	C0013018	[popg]	["Donors"-tx-1-"DONORS"-noun-0]	TX	31/6	
BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	3.46	Encounter due to being a donor	C1527169	[fndg]	["Donors"-tx-1-"DONORS"-noun-0]	TX	31/6	
BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	3.46	Healthy	C3898900	[qlco]	["Healthy"-tx-1-"HEALTHY"-adj-0]	TX	23/7	
BURKITT'S_LYMPHOMA	MMI	22.71	Burkitt Lymphoma	C0006413	[neop]	["BURKITT LYMPHOMA"-tx-1-"BURKITT LYMPHOMA"-noun-0]	TX	0/7,10/8	C02.256.466.313.165;C02.928.313.165;C04.557.386.480.150.165;C15.604.515.569.480.150.165;C20.683.515.761.480.150.165
BURKITT_LYMPHOMA	MMI	24.11	Burkitt Lymphoma	C0006413	[neop]	["BURKITT LYMPHOMA"-tx-1-"BURKITT LYMPHOMA"-noun-0]	TX	0/16	C02.256.466.313.165;C02.928.313.165;C04.557.386.480.150.165;C15.604.515.569.480.150.165;C20.683.515.761.480.150.165
CARCINOMA_HEPATOCELLULAR	MMI	13.14	Carcinoma	C0007097	[neop]	["CARCINOMA"-tx-1-"CARCINOMA"-noun-0]	TX	0/9	C04.557.470.200
CARCINOMA_HEPATOCELLULAR	MMI	3.50	Hepatocellular	C2697585	[qlco]	["Hepatocellular"-tx-1-"HEPATOCELLULAR"-adj-0]	TX	10/14	
CHOLANGIOCARCINOMA	MMI	20.95	Cholangiocarcinoma	C0206698	[neop]	["Cholangiocarcinoma"-tx-1-"CHOLANGIOCARCINOMA"-noun-0]	TX	0/18	C04.557.470.200.025.450
CHONDROSARCOMA	MMI	17.80	Chondrosarcoma	C0008479	[neop]	["CHONDROSARCOMA"-tx-1-"CHONDROSARCOMA"-noun-0]	TX	0/14	C04.557.450.565.280;C04.557.450.795.300
CHONDROSARCOMA	MMI	5.18	NCI CTEP SDC Chondrosarcoma Sub-Category Terminology	C3540851	[inpr]	["Chondrosarcoma"-tx-1-"CHONDROSARCOMA"-noun-0]	TX	0/14	
CHRONIC_LYMPHOCYTIC_LEUKEMIA_(CLL)	AA	CLL	CHRONIC LYMPHOCYTIC LEUKEMIA	1	3	5	28	30:3
CHRONIC_LYMPHOCYTIC_LEUKEMIA_(CLL)	MMI	20.95	Chronic Lymphocytic Leukemia	C0023434	[neop]	["Chronic lymphocytic leukaemia"-tx-1-"CHRONIC LYMPHOCYTIC LEUKEMIA"-noun-0]	TX	0/28	C04.557.337.428.080.125;C15.604.515.560.080.125;C20.683.515.528.080.125
CHRONIC_LYMPHOCYTIC_LEUKEMIA	MMI	20.95	Chronic Lymphocytic Leukemia	C0023434	[neop]	["Chronic lymphocytic leukaemia"-tx-1-"CHRONIC LYMPHOCYTIC LEUKEMIA"-noun-0]	TX	0/28	C04.557.337.428.080.125;C15.604.515.560.080.125;C20.683.515.528.080.125
CHRONIC_MYELOGENOUS_LEUKEMIA	MMI	17.80	Myeloid Leukemia, Chronic	C0023473	[neop]	["Chronic myelogenous leukaemia"-tx-1-"CHRONIC MYELOGENOUS LEUKEMIA"-noun-0]	TX	0/28	C04.557.337.539.250;C15.378.190.636.370
CHRONIC_MYELOID_LEUKEMIA	MMI	17.80	Myeloid Leukemia, Chronic	C0023473	[neop]	["Chronic myeloid leukaemia"-tx-1-"CHRONIC MYELOID LEUKEMIA"-noun-0]	TX	0/24	C04.557.337.539.250;C15.378.190.636.370
CHRONIC_MYELOID_LEUKEMIA	MMI	5.18	Chronic Myeloid Leukemia Pathway	C2984277	[ftcn]	["Chronic myeloid leukemia"-tx-1-"CHRONIC MYELOID LEUKEMIA"-noun-0]	TX	0/24	
CHRONIC_PANCREATITIS	MMI	14.64	Hereditary pancreatitis	C0238339	[dsyn]	["PANCREATITIS, CHRONIC"-tx-1-"CHRONIC PANCREATITIS"-noun-0]	TX	0/20	x.x.x.x
CHRONIC_PANCREATITIS	MMI	14.64	Pancreatitis, Chronic	C0149521	[dsyn]	["Chronic Pancreatitis"-tx-1-"CHRONIC PANCREATITIS"-noun-0]	TX	0/20	C06.689.750.830
CIRRHOSIS	MMI	11.49	Cirrhosis	C1623038	[dsyn]	["Cirrhosis"-tx-1-"CIRRHOSIS"-noun-0]	TX	0/9	C23.550.355
CIRRHOSIS	MMI	11.49	Liver Cirrhosis	C0023890	[dsyn]	["CIRRHOSIS"-tx-1-"CIRRHOSIS"-noun-0]	TX	0/9	C06.552.630
COLON_CARCINOMA,_HNPCC	MMI	12.94	MLH1 protein, human	C0252642	[aapp,bacs]	["HNPCC"-tx-1-"HNPCC"-noun-0]	TX	17/5	x.x.x.x
COLON_CARCINOMA,_HNPCC	MMI	3.75	Colon Carcinoma	C0699790	[neop]	["COLON CARCINOMA"-tx-1-"COLON CARCINOMA"-noun-0]	TX	0/15	
CROHN'S_DISEASE	MMI	17.80	Crohn Disease	C0010346	[dsyn]	["crohn s disease"-tx-1-"CROHN'DISEASE"-noun-0]	TX	0/5,5/1,8/7	C06.405.205.731.500;C06.405.469.432.500
CRYPTORCHIDISM	MMI	14.64	Cryptorchidism	C0010417	[cgab]	["CRYPTORCHIDISM"-tx-1-"CRYPTORCHIDISM"-noun-0]	TX	0/14	C12.294.829.258;C12.706.258;C16.131.939.258;C19.391.829.258
CUSHING'S_DISEASE	MMI	22.71	Pituitary-dependent Cushing's disease	C0221406	[dsyn]	["CUSHING DISEASE"-tx-1-"CUSHING DISEASE"-noun-0]	TX	0/7,10/7	C10.228.140.617.738.250.725;C19.700.355.800
DENGUE_HEMORRHAGIC_FEVER	MMI	20.95	Severe Dengue	C0019100	[dsyn]	["Dengue haemorrhagic fever"-tx-1-"DENGUE HEMORRHAGIC FEVER"-noun-0]	TX	0/24	C02.081.270.200;C02.782.350.250.214.200;C02.782.417.214.200
DENGUE_SHOCK_SYNDROME	MMI	20.95	Dengue Shock Syndrome	C0376300	[dsyn]	["Dengue Shock Syndrome"-tx-1-"DENGUE SHOCK SYNDROME"-noun-0]	TX	0/21	C02.081.270.200;C02.782.350.250.214.200;C02.782.417.214.200
DIFFUSE_LARGE_B-CELL_LYMPHOMA	MMI	24.11	Diffuse Large B-Cell Lymphoma	C0079744	[neop]	["Diffuse Large B-Cell Lymphoma"-tx-1-"DIFFUSE LARGE B-CELL LYMPHOMA"-noun-0]	TX	0/29	C04.557.386.480.150.585;C15.604.515.569.480.150.585;C20.683.515.761.480.150.585
DIFFUSE_LARGE_B-CELL_LYMPHOMA	MMI	5.18	Diffuse Large B-Cell Lymphoma, Not Otherwise Specified	C2699777	[neop]	["Diffuse Large B-Cell Lymphoma, Not Otherwise Specified"-tx-1-"DIFFUSE LARGE B-CELL LYMPHOMA"-noun-0]	TX	0/29	
DILATED_CARDIOMYOPATHY	MMI	14.64	Cardiomyopathy, Dilated	C0007193	[dsyn]	["Cardiomyopathy, Dilated"-tx-1-"DILATED CARDIOMYOPATHY"-noun-0]	TX	0/22	C14.280.195.160;C14.280.238.070
DILATED_CARDIOMYOPATHY	MMI	5.18	Dilated Cardiomyopathy Pathway	C2984282	[ftcn]	["Dilated cardiomyopathy"-tx-1-"DILATED CARDIOMYOPATHY"-noun-0]	TX	0/22	
DM1	MMI	5.18	MYOTONIC DYSTROPHY 1	C3250443	[dsyn]	["DM1"-tx-1-"DM1"-noun-0]	TX	0/3	
ENTERIC_VOLVULUS,_HEMORRHAGIC_INFARCT	MMI	16.23	Intestinal Volvulus	C0042961	[dsyn]	["Volvulus"-tx-1-"VOLVULUS"-noun-0]	TX	8/8	C06.405.469.531.568;C23.300.970.500
ENTERIC_VOLVULUS,_HEMORRHAGIC_INFARCT	MMI	3.50	Hemorrhagic infarct	C0333549	[patf]	["Hemorrhagic infarct"-tx-1-"HEMORRHAGIC INFARCT"-noun-0]	TX	18/19	
ENTERIC_VOLVULUS,_HEMORRHAGIC_INFARCT	MMI	3.47	Enteral	C1304890	[spco]	["Enteric"-tx-1-"ENTERIC"-adj-0]	TX	0/7	
EOSINOPHILIA	MMI	14.64	Eosinophilia	C0014457	[dsyn]	["EOSINOPHILIA"-tx-1-"EOSINOPHILIA"-noun-0]	TX	0/12	C15.378.553.231
EOSINOPHILIA	MMI	5.18	Eosinophil count raised (finding)	C2240374	[lbtr]	["Eosinophilia"-tx-1-"EOSINOPHILIA"-noun-0]	TX	0/12	
EOSINOPHILIA	MMI	5.18	Eosinophilic disorder	C1306759	[dsyn]	["Eosinophilia"-tx-1-"EOSINOPHILIA"-noun-0]	TX	0/12	
ESOPHAGEAL_ADENOCARCINOMA	MMI	14.64	Adenocarcinoma Of Esophagus	C0279628	[neop]	["Oesophageal Adenocarcinoma NOS"-tx-1-"ESOPHAGEAL ADENOCARCINOMA"-noun-0]	TX	0/25	x.x.x.x
ESOPHAGEAL_CANCER	MMI	17.80	Esophageal Neoplasms	C0014859	[neop]	["esophageal cancer"-tx-1-"ESOPHAGEAL CANCER"-noun-0]	TX	0/17	C04.588.274.476.205;C04.588.443.353;C06.301.371.205;C06.405.117.430;C06.405.249.205
ESOPHAGEAL_CANCER	MMI	5.18	Esophageal carcinoma	C0152018	[neop]	["ESOPHAGEAL CANCER"-tx-1-"ESOPHAGEAL CANCER"-noun-0]	TX	0/17	
ESOPHAGEAL_CANCER	MMI	5.18	Malignant neoplasm of esophagus	C0546837	[neop]	["Oesophageal cancer"-tx-1-"ESOPHAGEAL CANCER"-noun-0]	TX	0/17	
ESOPHAGEAL_SQUAMOUS_CELL_CARCINOMA	MMI	14.64	Squamous cell carcinoma of esophagus	C0279626	[neop]	["Esophageal Squamous Cell Carcinoma"-tx-1-"ESOPHAGEAL SQUAMOUS CELL CARCINOMA"-noun-0]	TX	0/34	x.x.x.x
EXTRANODAL_MARGINAL_ZONE_LYMPHOMA	MMI	22.73	Marginal Zone B-Cell Lymphoma	C1367654	[neop]	["Marginal Zone Lymphoma"-tx-1-"MARGINAL ZONE LYMPHOMA"-noun-0]	TX	11/22	C04.557.386.480.150.570;C15.604.515.569.480.150.570;C20.683.515.761.480.150.570
EXTRANODAL_MARGINAL_ZONE_LYMPHOMA	MMI	22.73	Mucosa-Associated Lymphoid Tissue Lymphoma	C0242647	[neop]	["marginal zone lymphoma"-tx-1-"MARGINAL ZONE LYMPHOMA"-noun-0]	TX	11/22	C04.557.386.480.150.570;C15.604.515.569.480.150.570;C20.683.515.761.480.150.570
EXTRANODAL_MARGINAL_ZONE_LYMPHOMA	MMI	3.47	Extranodal	C1517067	[spco]	["Extranodal"-tx-1-"EXTRANODAL"-adj-0]	TX	0/10	
FOLLICULAR_LYMPHOMA	MMI	20.95	Lymphoma, Follicular	C0024301	[neop]	["Follicular Lymphoma"-tx-1-"FOLLICULAR LYMPHOMA"-noun-0]	TX	0/19	C04.557.386.480.350;C15.604.515.569.480.350;C20.683.515.761.480.350
FRDA	MMI	14.64	FRIEDREICH ATAXIA 1	C1856689	[dsyn]	["FRDA"-tx-1-"FRDA"-noun-0]	TX	0/4	x.x.x.x
FTDALS1	MMI	5.18	AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	C1862937	[dsyn]	["FTDALS1"-tx-1-"FTDALS1"-noun-0]	TX	0/7	
HCC	MMI	20.95	Liver carcinoma	C2239176	[neop]	["HCC"-tx-1-"HCC"-noun-0]	TX	0/3	C04.557.470.200.025.255;C04.588.274.623.160;C06.301.623.160;C06.552.697.160
HCC	MMI	5.18	Hollings Cancer Center	C3539633	[prog]	["HCC"-tx-1-"HCC"-noun-0]	TX	0/3	
HCV_INFECTION	MMI	12.96	Hepatitis C virus	C0220847	[virs]	["HCV"-tx-1-"HCV"-noun-0]	TX	0/3	B04.450.410;B04.820.250.475
HCV_INFECTION	MMI	9.99	Communicable Diseases	C0009450	[dsyn]	["Infection, NOS"-tx-1-"INFECTION"-noun-0]	TX	4/9	C01.539.221
HCV_INFECTION	MMI	6.83	Infection	C3714514	[patf]	["INFECTION"-tx-1-"INFECTION"-noun-0]	TX	4/9	C01.539
HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA	MMI	13.33	Squamous cell carcinoma of the head and neck	C1168401	[neop]	["head neck Squamous Cell Carcinoma"-tx-1-"HEAD NECK SQUAMOUS CELL CARCINOMA"-noun-0]	TX	0/4,9/28	x.x.x.x
HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA	MMI	3.86	NCI CTEP SDC Head and Neck Squamous Cell Carcinoma Sub-Category Terminology	C3538931	[inpr]	["head neck Squamous Cell Carcinoma"-tx-1-"HEAD NECK SQUAMOUS CELL CARCINOMA"-noun-0]	TX	0/4,9/28	
HEAD_TRAUMA	MMI	11.49	Craniocerebral Trauma	C0018674	[inpo]	["HEAD TRAUMA"-tx-1-"HEAD TRAUMA"-noun-0]	TX	0/11	C10.900.300;C26.915.300
HEALTHY	MMI	5.18	Healthy	C3898900	[qlco]	["Healthy"-tx-1-"HEALTHY"-adj-0]	TX	0/7	
HEALTHY_CONTROL	MMI	5.18	Healthy Control	C2986479	[qlco]	["Healthy Control"-tx-1-"HEALTHY CONTROL"-noun-0]	TX	0/15	
HEALTHY_PATIENT	MMI	6.83	Patients	C0030705	[podg]	["*^patient"-tx-1-"PATIENT"-noun-0]	TX	8/7	M01.643
HEALTHY_PATIENT	MMI	3.68	Abortion consent:Finding:Point in time:^Patient:Document	C2360836	[clna]	["Patient"-tx-1-"PATIENT"-noun-0]	TX	8/7	
HEALTHY_PATIENT	MMI	3.68	Hysterectomy consent:Finding:Point in time:^Patient:Document	C2360838	[clna]	["Patient"-tx-1-"PATIENT"-noun-0]	TX	8/7	
HEALTHY_PATIENT	MMI	3.68	Sterilization consent:Finding:Point in time:^Patient:Document	C2360840	[clna]	["Patient"-tx-1-"PATIENT"-noun-0]	TX	8/7	
HEALTHY_PATIENT	MMI	3.50	Healthy	C3898900	[qlco]	["Healthy"-tx-1-"HEALTHY"-adj-0]	TX	0/7	
HEMOLYTIC_ANEMIA	MMI	14.64	Anemia, Hemolytic	C0002878	[dsyn]	["Haemolytic anaemia"-tx-1-"HEMOLYTIC ANEMIA"-noun-0]	TX	0/16	C15.378.071.141
HEMORRHAGIC_SHOCK_AFTER_CHOLECYSTECTOMY	MMI	13.14	Shock, Hemorrhagic	C0036982	[patf]	["Hemorrhagic Shock"-tx-1-"HEMORRHAGIC SHOCK"-noun-0]	TX	0/17	C23.550.414.980;C23.550.835.650
HEMORRHAGIC_SHOCK_AFTER_CHOLECYSTECTOMY	MMI	12.93	Cholecystectomy procedure	C0008320	[topp]	["CHOLECYSTECTOMY"-tx-1-"CHOLECYSTECTOMY"-noun-0]	TX	24/15	E04.210.120.172
HEPATITIS	MMI	17.80	Hepatitis A	C0019159	[dsyn]	["Hepatitis"-tx-1-"HEPATITIS"-noun-0]	TX	0/9	C02.440.420;C02.782.687.359.500;C06.552.380.705.422
HEPATITIS	MMI	11.49	Hepatitis	C0019158	[dsyn]	["HEPATITIS"-tx-1-"HEPATITIS"-noun-0]	TX	0/9	C06.552.380
HEPATOCELLULAR_CARCINOMA	MMI	20.95	Liver carcinoma	C2239176	[neop]	["HEPATOCELLULAR CARCINOMA"-tx-1-"HEPATOCELLULAR CARCINOMA"-noun-0]	TX	0/24	C04.557.470.200.025.255;C04.588.274.623.160;C06.301.623.160;C06.552.697.160
HIGH-GRADE_SEROUS_OVARIAN_CANCER_(HGSOC)	AA	HGSOC	HIGH-GRADE SEROUS OVARIAN CANCER	1	5	9	32	34:5
HIGH-GRADE_SEROUS_OVARIAN_CANCER_(HGSOC)	MMI	3.72	Ovarian Serous Adenocarcinoma	C1335177	[neop]	["Serous ovarian cancer"-tx-1-"SEROUS OVARIAN CANCER"-noun-0]	TX	11/21	
HIGH-GRADE_SEROUS_OVARIAN_CANCER_(HGSOC)	MMI	3.49	Severe (severity modifier)	C0205082	[qlco]	["High Grade"-tx-1-"HIGH-GRADE"-adj-0]	TX	0/10	
HLH	MMI	17.80	Lymphohistiocytosis, Hemophagocytic	C0024291	[dsyn]	["HLH"-tx-1-"HLH"-noun-0]	TX	0/3	C15.604.250.410.575
HODGKIN'S_LYMPHOMA	MMI	16.40	Hodgkin Disease	C0019829	[neop]	["HODGKIN LYMPHOMA"-tx-1-"HODGKIN LYMPHOMA"-noun-0]	TX	0/7,10/8	C04.557.386.355;C15.604.515.569.355;C20.683.515.761.355
HODGKIN'S_LYMPHOMA	MMI	3.78	NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology	C3541281	[inpr]	["Hodgkin Lymphoma"-tx-1-"HODGKIN LYMPHOMA"-noun-0]	TX	0/7,10/8	
HUMAN_IMMUNODEFICIENCY_VIRUS_INFECTIOUS_DISEASE	MMI	16.45	HIV Infections	C0019693	[dsyn]	["Human immunodeficiency virus disease"-tx-1-"HUMAN IMMUNODEFICIENCY VIRUS DISEASE"-noun-0]	TX	0/28,40/7	C02.782.815.616.400;C02.800.801.400;C20.673.480
HUMAN_IMMUNODEFICIENCY_VIRUS_INFECTIOUS_DISEASE	MMI	9.84	Communicable Diseases	C0009450	[dsyn]	["Infection, NOS"-tx-1-"INFECTIOUS"-noun-0]	TX	29/10	C01.539.221
HUMAN_IMMUNODEFICIENCY_VIRUS_INFECTIOUS_DISEASE	MMI	6.69	Infection	C3714514	[patf]	["Infections"-tx-1-"INFECTIOUS"-noun-0]	TX	29/10	C01.539
HUNTINGTON'S_DISEASE	MMI	19.55	Huntington Disease	C0020179	[dsyn]	["HUNTINGTON DISEASE"-tx-1-"HUNTINGTON DISEASE"-noun-0]	TX	0/10,13/7	C10.228.140.079.545;C10.228.140.380.278;C10.228.662.262.249.750;C10.574.500.497;C16.320.400.430;F03.615.250.400;F03.615.400.390
HUNTINGTON'S_DISEASE	MMI	3.78	Huntington's Disease Pathway	C2919056	[ftcn]	["Huntington's Disease"-tx-1-"HUNTINGTON DISEASE"-noun-0]	TX	0/10,13/7	
HUTCHINSON-GILFORD_PROGERIA_SYNDROME	MMI	14.64	Progeria	C0033300	[dsyn]	["HUTCHINSON-GILFORD PROGERIA SYNDROME"-tx-1-"HUTCHINSON-GILFORD PROGERIA SYNDROME"-noun-0]	TX	0/36	C16.320.565.753;C18.452.648.753
HUTCHINSON-GILFORD_PROGERIA_SYNDROME	MMI	5.18	ZMPSTE24 gene	C1421586	[gngm]	["Hutchinson-Gilford progeria syndrome"-tx-1-"HUTCHINSON-GILFORD PROGERIA SYNDROME"-noun-0]	TX	0/36	
HUTINGTON'S_DISEASE_PATIENT	MMI	3.68	patient condition	C0683521	[fndg]	["Disease patient"-tx-1-"DISEASE PATIENT"-noun-0]	TX	12/15	
HYPERLIPIDEMIA	MMI	17.80	Hyperlipidemia	C0020473	[dsyn]	["Hyperlipidaemia, NOS"-tx-1-"HYPERLIPIDEMIA"-noun-0]	TX	0/14	C18.452.584.500.500
HYPERLIPIDEMIA	MMI	5.18	Serum lipids high (finding)	C0428465	[fndg]	["Hyperlipidemia"-tx-1-"HYPERLIPIDEMIA"-noun-0]	TX	0/14	
HYPERTENSIVE_CEREBRAL_HEMORRHAGE	MMI	20.95	Cerebral Hemorrhage, Hypertensive	C0751892	[patf]	["hypertensive Cerebral haemorrhage"-tx-1-"HYPERTENSIVE CEREBRAL HEMORRHAGE"-noun-0]	TX	0/32	C10.228.140.300.535.325;C14.907.253.573.350
HYPER_IGD_SYNDROME_(HIDS)	AA	HIDS	HYPER IGD SYNDROME	1	4	5	18	20:4
HYPER_IGD_SYNDROME_(HIDS)	MMI	20.95	Hyperimmunoglobulinemia D	C0398691	[dsyn]	["HYPER-IgD SYNDROME"-tx-1-"HYPER IGD SYNDROME"-noun-0]	TX	0/18	C10.228.140.163.100.593;C15.378.147.542.319;C16.320.382.750;C16.320.565.189.593;C16.320.565.663.430;C18.452.132.100.593;C18.452.648.189.593;C18.452.648.663.430;C20.683.460.319
HYPER_IGD_SYNDROME	MMI	20.95	Hyperimmunoglobulinemia D	C0398691	[dsyn]	["HYPER-IgD SYNDROME"-tx-1-"HYPER IGD SYNDROME"-noun-0]	TX	0/18	C10.228.140.163.100.593;C15.378.147.542.319;C16.320.382.750;C16.320.565.189.593;C16.320.565.663.430;C18.452.132.100.593;C18.452.648.189.593;C18.452.648.663.430;C20.683.460.319
HYPOMYELINATING_LEUKODYSTROPHY	MMI	5.18	Leukodystrophy, hypomyelinating	C2677112	[fndg]	["Leukodystrophy, hypomyelinating"-tx-1-"HYPOMYELINATING LEUKODYSTROPHY"-noun-0]	TX	0/30	
HYPOPHARYNGEAL_SQUAMOUS_CELL_CARCINOMA	MMI	5.18	hypopharyngeal squamous cell carcinoma	C0280321	[neop]	["Hypopharyngeal Squamous Cell Carcinoma"-tx-1-"HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA"-noun-0]	TX	0/38	
H	MMI	20.95	Protons	C0033727	[elii]	["H+"-tx-1-"H"-noun-0]	TX	0/1	D01.248.497.300.459.700;D01.268.406.750;D01.362.340.750;G01.249.765
H	MMI	5.18	/hour	C0564385	[qnco]	["/h"-tx-1-"H"-noun-0]	TX	0/1	
H	MMI	5.18	H NOS Antibodies	C0369286	[aapp,imft]	["H NOS"-tx-1-"H"-noun-0]	TX	0/1	
H	MMI	5.18	Hepatic Involvement	C0441932	[clas]	["H+"-tx-1-"H"-noun-0]	TX	0/1	
ICHTHYOSIS_VULGARIS_(IV)	AA	IV	ICHTHYOSIS VULGARIS	1	2	3	19	21:2
ICHTHYOSIS_VULGARIS_(IV)	MMI	17.80	Ichthyosis Vulgaris	C0079584	[cgab,dsyn]	["ICHTHYOSIS VULGARIS"-tx-1-"ICHTHYOSIS VULGARIS"-noun-0]	TX	0/19	C16.131.831.512.410;C16.320.850.405;C17.800.428.333.410;C17.800.804.512.410;C17.800.827.405
LISSENCEPHALY(XLAG)	MMI	19.45	Lissencephaly	C0266463	[cgab]	["Lissencephaly"-tx-1-"LISSENCEPHALY"-noun-0]	TX	0/13	C10.500.507.450.499;C16.131.666.507.450.499
LISSENCEPHALY(XLAG)	MMI	12.96	Lissencephaly, X-Linked, 2	C1846171	[dsyn]	["XLAG"-tx-1-"XLAG"-noun-0]	TX	14/4	x.x.x.x
LISSENCEPHALY(XLAG)	MMI	3.50	CHROMOSOME Xq26.3 DUPLICATION SYNDROME	C3891556	[dsyn]	["XLAG"-tx-1-"XLAG"-noun-0]	TX	14/4	
LISSENCEPHALY	MMI	20.95	Lissencephaly	C0266463	[cgab]	["Lissencephaly"-tx-1-"LISSENCEPHALY"-noun-0]	TX	0/13	C10.500.507.450.499;C16.131.666.507.450.499
LYMPHOMA	MMI	14.64	Lymphoma	C0024299	[neop]	["LYMPHOMA"-tx-1-"LYMPHOMA"-noun-0]	TX	0/8	C04.557.386;C15.604.515.569;C20.683.515.761
LYMPHOPLAMACYTIC_LYMPHOMA	MMI	13.14	Lymphoma	C0024299	[neop]	["LYMPHOMA"-tx-1-"LYMPHOMA"-noun-0]	TX	17/8	C04.557.386;C15.604.515.569;C20.683.515.761
MATCHED_SKIN	MMI	6.83	Skin	C1123023	[bdsy]	["SKIN"-tx-1-"SKIN"-noun-0]	TX	8/4	A17.815
MATCHED_SKIN	MMI	3.68	Entire skin	C1278993	[bdsy]	["Skin"-tx-1-"SKIN"-noun-0]	TX	8/4	
MATCHED_SKIN	MMI	3.68	Skin Specimen	C0444099	[bdsu]	["Skin"-tx-1-"SKIN"-noun-0]	TX	8/4	
MATCHED_SKIN	MMI	3.50	MATCHING	C0150103	[resa]	["matched"-tx-1-"MATCHED"-adj-0]	TX	0/7	
MATCHED_SKIN	MMI	3.50	Match	C1708943	[qlco]	["Matched"-tx-1-"MATCHED"-adj-0]	TX	0/7	
MDS	MMI	5.18	YWHAE wt Allele	C3539662	[gngm]	["MDS"-tx-1-"MDS"-noun-0]	TX	0/3	
MESOTHELIOMA	MMI	17.80	Mesothelioma	C0025500	[neop]	["MESOTHELIOMA"-tx-1-"MESOTHELIOMA"-noun-0]	TX	0/12	C04.557.470.035.510;C04.557.470.660.510
MESOTHELIOMA	MMI	5.18	Mesothelioma (malignant, clinical disorder) (disorder)	C1290375	[neop]	["Mesothelioma"-tx-1-"MESOTHELIOMA"-noun-0]	TX	0/12	
MESOTHELIOMA	MMI	5.18	NCI CTEP SDC Mesothelioma Sub-Category Terminology	C3538785	[inpr]	["Mesothelioma"-tx-1-"MESOTHELIOMA"-noun-0]	TX	0/12	
MITOCHONDRIAL_DISEASE	MMI	11.49	Mitochondrial Diseases	C0751651	[dsyn]	["Disease, Mitochondrial"-tx-1-"MITOCHONDRIAL DISEASE"-noun-0]	TX	0/21	C18.452.660
MS	MMI	20.95	5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase	C0039676	[aapp,enzy]	["MS"-tx-1-"MS"-noun-0]	TX	0/2	D08.811.913.555.500.645
MYASTHENIA_GRAVIS	MMI	14.64	Myasthenia Gravis	C0026896	[dsyn]	["MYASTHENIA GRAVIS"-tx-1-"MYASTHENIA GRAVIS"-noun-0]	TX	0/17	C10.114.656;C10.668.758.725;C20.111.258.500
MYOEPITHELIAL_CARCINOMA_OF_SALIVARY_GLAND	MMI	3.85	Salivary gland carcinoma	C0948750	[neop]	["Carcinoma of Salivary Gland"-tx-1-"CARCINOMA OF SALIVARY GLAND"-noun-0]	TX	14/27	
MYOEPITHELIAL_CARCINOMA_OF_SALIVARY_GLAND	MMI	3.46	Myoepithelial	C1513794	[spco]	["Myoepithelial"-tx-1-"MYOEPITHELIAL"-adj-0]	TX	0/13	
NASOPHARYNGEAL_CARCINOMA	MMI	14.64	Nasopharyngeal carcinoma	C2931822	[neop]	["NASOPHARYNGEAL CARCINOMA"-tx-1-"NASOPHARYNGEAL CARCINOMA"-noun-0]	TX	0/24	x.x.x.x
NEOPLASTIC,_ESOPHAGEAL_SQUAMOUS_CELL_CARCINOMA	MMI	13.31	Squamous cell carcinoma of esophagus	C0279626	[neop]	["Esophageal Squamous Cell Carcinoma"-tx-1-"ESOPHAGEAL SQUAMOUS CELL CARCINOMA"-noun-0]	TX	12/34	x.x.x.x
NEOPLASTIC,_ESOPHAGEAL_SQUAMOUS_CELL_CARCINOMA	MMI	3.46	Neoplastic	C1709160	[qlco]	["Neoplastic"-tx-1-"NEOPLASTIC"-adj-0]	TX	0/10	
NEPHRONOPHTHISIS	MMI	5.18	Nephronophthisis	C0687120	[dsyn]	["Nephronophthisis"-tx-1-"NEPHRONOPHTHISIS"-noun-0]	TX	0/16	
NODAL_MARGINAL_ZONE_LYMPHOMA	MMI	24.11	Mucosa-Associated Lymphoid Tissue Lymphoma	C0242647	[neop]	["Nodal marginal zone lymphoma"-tx-1-"NODAL MARGINAL ZONE LYMPHOMA"-noun-0]	TX	0/28	C04.557.386.480.150.570;C15.604.515.569.480.150.570;C20.683.515.761.480.150.570
NODAL_MARGINAL_ZONE_LYMPHOMA	MMI	5.18	Monocytoid B-cell lymphoma	C0855139	[neop]	["Nodal Marginal Zone Lymphoma"-tx-1-"NODAL MARGINAL ZONE LYMPHOMA"-noun-0]	TX	0/28	
NON-SIGNIFICANT_ATHEROSCLEROSIS	MMI	16.25	Atherosclerosis	C0004153	[dsyn]	["ATHEROSCLEROSIS"-tx-1-"ATHEROSCLEROSIS"-noun-1]	TX	16/15	C14.907.137.126.307
NON-SIGNIFICANT_ATHEROSCLEROSIS	MMI	13.09	Arteriosclerosis	C0003850	[dsyn]	["ATHEROSCLEROSIS"-tx-1-"ATHEROSCLEROSIS"-noun-1]	TX	16/15	C14.907.137.126
NON-SIGNIFICANT_ATHEROSCLEROSIS	MMI	3.48	Event Seriousness - Significant	C1546944	[qlco]	["Significant"-tx-1-"SIGNIFICANT"-adj-0]	TX	4/11	
NON-SIGNIFICANT_ATHEROSCLEROSIS	MMI	3.48	Negation	C1518422	[ftcn]	["Non"-tx-1-"NON"-adj-0]	TX	0/3	
NON-SIGNIFICANT_ATHEROSCLEROSIS	MMI	3.48	Significant	C0750502	[idcn]	["Significant"-tx-1-"SIGNIFICANT"-adj-0]	TX	4/11	
NON-SIGNIFICANT_ATHEROSCLEROSIS	MMI	3.48	Statistical Significance	C0237881	[qnco]	["significant"-tx-1-"SIGNIFICANT"-adj-0]	TX	4/11	
NONE_(HEALTHY_CONTROL)	MMI	3.75	Healthy Control	C2986479	[qlco]	["Healthy Control"-tx-1-"HEALTHY CONTROL"-noun-0]	TX	6/15	
NO_KNOWN_CARDIAC_DISEASES	MMI	6.83	Heart Diseases	C0018799	[dsyn]	["Cardiac Diseases"-tx-1-"CARDIAC DISEASES"-noun-1]	TX	9/16	C14.280
OSTEOARTHRITIS	MMI	14.64	Degenerative polyarthritis	C0029408	[dsyn]	["OSTEOARTHRITIS"-tx-1-"OSTEOARTHRITIS"-noun-0]	TX	0/14	C05.550.114.606;C05.799.613
OTHER_FEBRILE_ILLNESS	MMI	3.75	Disorder characterized by fever	C0743841	[dsyn]	["Febrile illness"-tx-1-"FEBRILE ILLNESS"-noun-0]	TX	6/15	
OVARIAN_EPITHELIAL-SEROUS_CARCINOMA	MMI	13.27	Epithelial ovarian cancer	C0677886	[neop]	["ovarian epithelial carcinoma"-tx-1-"OVARIAN EPITHELIAL CARCINOMA"-noun-0]	TX	0/18,26/9	x.x.x.x
OVARIAN_EPITHELIAL-SEROUS_CARCINOMA	MMI	3.81	Ovarian Serous Adenocarcinoma	C1335177	[neop]	["Ovarian Serous Carcinoma"-tx-1-"OVARIAN SEROUS CARCINOMA"-noun-0]	TX	0/7,19/16	
OVARIAN_EPITHELIAL-SEROUS_CARCINOMA	MMI	3.47	Serous	C0440743	[qlco]	["Serous"-tx-1-"SEROUS"-adj-0]	TX	19/6	
OVARIAN_EPITHELIAL-SEROUS_CARCINOMA	MMI	3.47	epithelial	C0221908	[qlco]	["Epithelial"-tx-1-"EPITHELIAL"-adj-0]	TX	8/10	
PAPILLARY_THYROID_CARCINOMA	MMI	14.64	Papillary thyroid carcinoma	C0238463	[neop]	["Papillary Thyroid Carcinoma"-tx-1-"PAPILLARY THYROID CARCINOMA"-noun-0]	TX	0/27	x.x.x.x
PARATYPHI_INFECTION	MMI	9.99	Communicable Diseases	C0009450	[dsyn]	["Infection, NOS"-tx-1-"INFECTION"-noun-0]	TX	10/9	C01.539.221
PARATYPHI_INFECTION	MMI	6.83	Infection	C3714514	[patf]	["INFECTION"-tx-1-"INFECTION"-noun-0]	TX	10/9	C01.539
PARATYPHI_INFECTION	MMI	3.50	Paratyphi	C1979958	[orgm]	["Paratyphi"-tx-1-"PARATYPHI"-noun-0]	TX	0/9	
PATIENTS_WITH_BONE_MARROW_FAILURE_AND_CYTOGENETIC_ABNORMALITIES	MMI	12.93	Chromosome Aberrations	C0008625	[comd]	["Cytogenetic Abnormalities"-tx-1-"CYTOGENETIC ABNORMALITIES"-noun-0]	TX	38/25	C23.550.210;G05.365.590.175
PATIENTS_WITH_BONE_MARROW_FAILURE_AND_CYTOGENETIC_ABNORMALITIES	MMI	9.79	Pancytopenia	C0030312	[dsyn]	["Bone Marrow Failure"-tx-1-"BONE MARROW FAILURE"-noun-0]	TX	14/19	C15.378.700
PATIENTS_WITH_BONE_MARROW_FAILURE_AND_CYTOGENETIC_ABNORMALITIES	MMI	9.77	Congenital chromosomal disease	C0008626	[cgab,dsyn]	["Cytogenetic Abnormalities"-tx-1-"CYTOGENETIC ABNORMALITIES"-noun-0]	TX	38/25	C16.131.260;C16.320.180
PATIENTS_WITH_BONE_MARROW_FAILURE_AND_CYTOGENETIC_ABNORMALITIES	MMI	6.75	Patients	C0030705	[podg]	["Patients"-tx-1-"PATIENTS"-noun-0]	TX	0/8	M01.643
PATIENTS_WITH_BONE_MARROW_FAILURE_AND_CYTOGENETIC_ABNORMALITIES	MMI	3.48	Bone marrow hypocellularity	C1855710	[fndg]	["Bone marrow failure"-tx-1-"BONE MARROW FAILURE"-noun-0]	TX	14/19	
PEMPHIGUS_VULGARIS	MMI	14.64	Pemphigus Vulgaris	C0030809	[dsyn]	["PEMPHIGUS VULGARIS"-tx-1-"PEMPHIGUS VULGARIS"-noun-0]	TX	0/18	C17.800.865.716;C20.111.736
PNH	MMI	5.18	Paroxysmal nocturnal hemoglobinuria	C0024790	[dsyn]	["PNH"-tx-1-"PNH"-noun-0]	TX	0/3	
PRIMARY_ANTIPHOSPHOLIPID_SYNDROME	MMI	5.18	Primary antiphospholipid syndrome	C0409980	[dsyn]	["Primary antiphospholipid syndrome"-tx-1-"PRIMARY ANTIPHOSPHOLIPID SYNDROME"-noun-0]	TX	0/33	
PRIMARY_CUTANEOUS_CD30+_T-CELL_LYMPHOPROLIFERATIVE_DISORDER	MMI	5.18	Primary cutaneous CD30+ T-cell lymphoproliferative disorder	C1371159	[neop]	["Primary Cutaneous CD30+ T-Cell Lymphoproliferative Disorder"-tx-1-"PRIMARY CUTANEOUS CD30 T-CELL LYMPHOPROLIFERATIVE DISORDER"-noun-0]	TX	0/22,24/35	
PULMONARY_HYPERTENSION	MMI	11.49	Pulmonary Hypertension	C0020542	[patf]	["Hypertension, pulmonary"-tx-1-"PULMONARY HYPERTENSION"-noun-0]	TX	0/22	C08.381.423
PULMONARY_HYPERTENSION	MMI	5.18	Pulmonary Hypertension Adverse Event	C1963220	[fndg]	["Pulmonary hypertension"-tx-1-"PULMONARY HYPERTENSION"-noun-0]	TX	0/22	
RDEB	MMI	17.80	Hallopeau-Siemens Disease	C0079474	[dsyn]	["RDEB"-tx-1-"RDEB"-noun-0]	TX	0/4	C16.131.831.493.160;C16.320.850.275.160;C17.300.200.367;C17.800.804.493.160;C17.800.827.275.160;C17.800.865.410.160
RHEUMATOID_ARTHRITIS_(EARLY)	MMI	13.22	Rheumatoid Arthritis	C0003873	[dsyn]	["RHEUMATOID ARTHRITIS"-tx-1-"RHEUMATOID ARTHRITIS"-noun-0]	TX	0/20	C05.550.114.154;C05.799.114;C17.300.775.099;C20.111.199
RHEUMATOID_ARTHRITIS_(EARLY)	MMI	3.48	Early	C1279919	[tmco]	["Early"-tx-1-"EARLY"-adv-0]	TX	22/5	
RHEUMATOID_ARTHRITIS_(ESTABLISHED)	MMI	13.22	Rheumatoid Arthritis	C0003873	[dsyn]	["RHEUMATOID ARTHRITIS"-tx-1-"RHEUMATOID ARTHRITIS"-noun-0]	TX	0/20	C05.550.114.154;C05.799.114;C17.300.775.099;C20.111.199
RHEUMATOID_ARTHRITIS_(ESTABLISHED)	MMI	3.48	Accepted	C1272684	[qlco]	["Established"-tx-1-"ESTABLISHED"-adj-0]	TX	22/11	
RHEUMATOID_ARTHRITIS_(ESTABLISHED)	MMI	3.48	Established	C0443211	[qlco]	["Established"-tx-1-"ESTABLISHED"-adj-0]	TX	22/11	
RHEUMATOID_ARTHRITIS	MMI	14.64	Rheumatoid Arthritis	C0003873	[dsyn]	["RHEUMATOID ARTHRITIS"-tx-1-"RHEUMATOID ARTHRITIS"-noun-0]	TX	0/20	C05.550.114.154;C05.799.114;C17.300.775.099;C20.111.199
ROTHMUND-THOMSON_SYNDROME	MMI	14.64	Rothmund-Thomson syndrome	C0032339	[dsyn]	["ROTHMUND-THOMSON SYNDROME"-tx-1-"ROTHMUND-THOMSON SYNDROME"-noun-0]	TX	0/25	C16.131.831.775;C16.320.850.765;C16.614.760;C17.800.804.775;C17.800.827.775;C18.452.284.760
SBH	MMI	24.11	Subcortical Band Heterotopia	C1848201	[dsyn]	["SBH"-tx-1-"SBH"-noun-0]	TX	0/3	C10.500.507.450.230;C10.500.507.450.499.230;C16.131.666.507.450.230;C16.131.666.507.450.499.230;C16.320.322.500.186
SBH	MMI	14.64	SUBCORTICAL BAND HETEROTOPIA, X-LINKED	C1848200	[dsyn]	["SBH"-tx-1-"SBH"-noun-0]	TX	0/3	x.x.x.x
SMALL_B_CELL_LYMPHOMA,_UNSPECIFIED	MMI	3.84	Unspecified B-cell lymphoma	C0348396	[neop]	["Unspecified B-cell lymphoma"-tx-1-"B CELL LYMPHOMA UNSPECIFIED"-noun-0]	TX	6/15,23/11	
SMALL_B_CELL_LYMPHOMA,_UNSPECIFIED	MMI	3.60	Small	C0700321	[qnco]	["SMALL"-tx-1-"SMALL"-noun-0]	TX	0/5	
SMA_TYPE_I	MMI	16.40	HMN (Hereditary Motor Neuropathy) Proximal Type I	C0043116	[dsyn]	["SMA I"-tx-1-"SMA I"-noun-0]	TX	0/3,9/1	C10.228.854.468.800;C10.574.500.812;C10.574.562.500.750;C10.668.467.500.750;C16.320.400.765
SPLENIC_MARGINAL_ZONE_LYMPHOMA	MMI	5.18	Splenic Marginal Zone B-Cell Lymphoma	C0349632	[neop]	["Splenic Marginal Zone Lymphoma"-tx-1-"SPLENIC MARGINAL ZONE LYMPHOMA"-noun-0]	TX	0/30	
STEROID-RESISTANT_NEPHROTIC_SYNDROME	MMI	5.18	Steroid resistant nephrotic syndrome of childhood	C3266102	[dsyn]	["Steroid-Resistant Nephrotic Syndrome"-tx-1-"STEROID-RESISTANT NEPHROTIC SYNDROME"-noun-0]	TX	0/36	
STEROID-RESISTANT_NEPHROTIC_SYNDROME	MMI	5.18	Steroid-resistant nephrotic syndrome	C0403397	[dsyn]	["Nephrotic syndrome, steroid-resistant"-tx-1-"STEROID-RESISTANT NEPHROTIC SYNDROME"-noun-0]	TX	0/36	
STOMACH	MMI	14.64	Stomach	C0038351	[bpoc]	["STOMACH"-tx-1-"STOMACH"-noun-0]	TX	0/7	A03.556.875.875
STOMACH	MMI	5.18	Entire stomach	C1278920	[bpoc]	["Stomach"-tx-1-"STOMACH"-noun-0]	TX	0/7	
STOMACH	MMI	5.18	Gastric Tissue	C1517454	[tisu]	["STOMACH"-tx-1-"STOMACH"-noun-0]	TX	0/7	
STOMACH	MMI	5.18	Stomach structure	C3714551	[bpoc]	["Stomach"-tx-1-"STOMACH"-noun-0]	TX	0/7	
SUDDEN_CARDIAC_DEATH	MMI	17.80	Sudden Cardiac Death	C0085298	[patf]	["SUDDEN CARDIAC DEATH"-tx-1-"SUDDEN CARDIAC DEATH"-noun-0]	TX	0/20	C14.280.383.220;C23.550.260.322.250
SYSTEMIC_ANAPHYLACTIC_SHOCK	MMI	13.22	anaphylaxis	C0002792	[patf]	["ANAPHYLACTIC SHOCK"-tx-1-"ANAPHYLACTIC SHOCK"-noun-0]	TX	9/18	C20.543.480.099
SYSTEMIC_ANAPHYLACTIC_SHOCK	MMI	3.48	Systemic	C0205373	[ftcn]	["Systemic"-tx-1-"SYSTEMIC"-adj-0]	TX	0/8	
TERMINAL_HEART_FAILURE	MMI	10.06	Heart failure	C0018801	[dsyn]	["Failure, Heart"-tx-1-"HEART FAILURE"-noun-0]	TX	9/13	C14.280.434
TERMINAL_HEART_FAILURE	MMI	3.75	Congestive heart failure	C0018802	[dsyn]	["Heart Failure"-tx-1-"HEART FAILURE"-noun-0]	TX	9/13	
TERMINAL_HEART_FAILURE	MMI	3.48	End-stage	C0205088	[qlco]	["Terminal"-tx-1-"TERMINAL"-adj-0]	TX	0/8	
TERMINAL_HEART_FAILURE	MMI	3.48	Terminal (end postition)	C1705315	[spco]	["Terminal"-tx-1-"TERMINAL"-adj-0]	TX	0/8	
TERMINAL_HEART_FAILURE	MMI	3.48	Terminal Device Component	C1705314	[mnob]	["Terminal"-tx-1-"TERMINAL"-adj-0]	TX	0/8	
THERAPY-RELATED_AML	MMI	22.40	therapeutic aspects	C0039798	[ftcn]	["therapy"-tx-1-"THERAPY"-noun-0]	TX	0/7	x.x.x.x.x.x.x
THERAPY-RELATED_AML	MMI	16.25	Leukemia, Myelocytic, Acute	C0023467	[neop]	["AML"-tx-1-"AML"-noun-0]	TX	16/3	C04.557.337.539.275
THERAPY-RELATED_AML	MMI	3.48	Related personal status	C0445223	[fndg]	["Related"-tx-1-"RELATED"-adj-0]	TX	8/7	
THERAPY-RELATED_AML	MMI	3.48	Relationships	C0439849	[qlco]	["Related"-tx-1-"RELATED"-adj-0]	TX	8/7	
THERAPY-RELATED_AML	MMI	3.48	Therapeutic procedure	C0087111	[topp]	["Therapy"-tx-1-"THERAPY"-noun-0]	TX	0/7	E02
THERAPY-RELATED_AML	MMI	3.48	Therapy Object (animal model)	C1363945	[fndg]	["Therapy"-tx-1-"THERAPY"-noun-0]	TX	0/7	
THYROID	MMI	11.49	Thyroid Gland	C0040132	[bpoc]	["Thyroid, NOS"-tx-1-"THYROID"-noun-0]	TX	0/7	A06.407.900
THYROID	MMI	5.18	THYROID DIAGNOSTIC RADIOPHARMACEUTICALS	C3540038	[irda]	["THYROID"-tx-1-"THYROID"-noun-0]	TX	0/7	
THYROID_CANCER	MMI	5.18	Malignant neoplasm of thyroid	C0007115	[neop]	["-- Thyroid Cancer"-tx-1-"THYROID_CANCER"-noun-0]	TX	0/14	
THYROID_CANCER	MMI	5.18	NCI CTEP SDC Thyroid Cancer Sub-Category Terminology	C3541337	[inpr]	["Thyroid Cancer"-tx-1-"THYROID_CANCER"-noun-0]	TX	0/14	
THYROID_CANCER	MMI	5.18	Papillary Thyroid Carcinoma Pathway	C2984307	[cnce]	["Thyroid cancer"-tx-1-"THYROID_CANCER"-noun-0]	TX	0/14	
THYROID_CANCER	MMI	5.18	Thyroid carcinoma	C0549473	[neop]	["Cancer, Thyroid"-tx-1-"THYROID_CANCER"-noun-0]	TX	0/14	
T_LYMPHOBLASTIC_LEUKEMIA_LYMPHOMA	MMI	5.18	Precursor T cell lymphoblastic leukemia/lymphoblastic lymphoma	C1301359	[neop]	["T lymphoblastic leukaemia/lymphoma"-tx-1-"T LYMPHOBLASTIC LEUKEMIA LYMPHOMA"-noun-0]	TX	0/33	
UNDIFFERENTIATED_ARTHRITIS	MMI	5.18	Undifferentiated inflammatory arthritis	C1562028	[dsyn]	["Undifferentiated Arthritis"-tx-1-"UNDIFFERENTIATED ARTHRITIS"-noun-0]	TX	0/26	
UROTHELIAL_BLADDER_CARCINOMA	MMI	5.18	Transitional cell carcinoma of bladder	C0279680	[neop]	["Urothelial Bladder carcinoma"-tx-1-"UROTHELIAL BLADDER CARCINOMA"-noun-0]	TX	0/28	
VISCERAL_LEISHMANIASIS	MMI	17.80	Leishmaniasis, Visceral	C0023290	[dsyn]	["LEISHMANIASIS, VISCERAL"-tx-1-"VISCERAL LEISHMANIASIS"-noun-0]	TX	0/22	C03.752.300.500.510
WELL-DIFFERENTIATED_HEPATOCELLULAR_CARCINOMA	MMI	5.18	Well Differentiated Hepatocellular Carcinoma	C3273033	[neop]	["Well Differentiated Hepatocellular Carcinoma"-tx-1-"WELL-DIFFERENTIATED HEPATOCELLULAR CARCINOMA"-noun-0]	TX	0/44	
HEALTHY  15
BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	9.99	Bone Marrow Cells	C0005955	[cell]	["Bone Marrow Cells"-tx-1-"BONE MARROW CELLS"-noun-0]	TX	0/17	A11.148;A15.378.316
BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	3.76	Encounter for being a bone marrow donor	C1313934	[fndg]	["Bone marrow donors"-tx-1-"BONE MARROW DONORS"-noun-0]	TX	0/11,31/6	
BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	3.60	Cells	C0007634	[cell]	["Cells"-tx-1-"CELLS"-noun-0]	TX	12/5	A11
BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	3.60	Cells [Chemical/Ingredient]	C3282337	[cell]	["Cells"-tx-1-"CELLS"-noun-0]	TX	12/5	
BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	3.46	Donor person	C0013018	[popg]	["Donors"-tx-1-"DONORS"-noun-0]	TX	31/6	
BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	3.46	Encounter due to being a donor	C1527169	[fndg]	["Donors"-tx-1-"DONORS"-noun-0]	TX	31/6	
BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	3.46	Healthy	C3898900	[qlco]	["Healthy"-tx-1-"HEALTHY"-adj-0]	TX	23/7	
HEALTHY	MMI	5.18	Healthy	C3898900	[qlco]	["Healthy"-tx-1-"HEALTHY"-adj-0]	TX	0/7	
HEALTHY_CONTROL	MMI	5.18	Healthy Control	C2986479	[qlco]	["Healthy Control"-tx-1-"HEALTHY CONTROL"-noun-0]	TX	0/15	
HEALTHY_PATIENT	MMI	6.83	Patients	C0030705	[podg]	["*^patient"-tx-1-"PATIENT"-noun-0]	TX	8/7	M01.643
HEALTHY_PATIENT	MMI	3.68	Abortion consent:Finding:Point in time:^Patient:Document	C2360836	[clna]	["Patient"-tx-1-"PATIENT"-noun-0]	TX	8/7	
HEALTHY_PATIENT	MMI	3.68	Hysterectomy consent:Finding:Point in time:^Patient:Document	C2360838	[clna]	["Patient"-tx-1-"PATIENT"-noun-0]	TX	8/7	
HEALTHY_PATIENT	MMI	3.68	Sterilization consent:Finding:Point in time:^Patient:Document	C2360840	[clna]	["Patient"-tx-1-"PATIENT"-noun-0]	TX	8/7	
HEALTHY_PATIENT	MMI	3.50	Healthy	C3898900	[qlco]	["Healthy"-tx-1-"HEALTHY"-adj-0]	TX	0/7	
NONE_(HEALTHY_CONTROL)	MMI	3.75	Healthy Control	C2986479	[qlco]	["Healthy Control"-tx-1-"HEALTHY CONTROL"-noun-0]	TX	6/15	
HEALTHY_CONTROL  2
HEALTHY_CONTROL	MMI	5.18	Healthy Control	C2986479	[qlco]	["Healthy Control"-tx-1-"HEALTHY CONTROL"-noun-0]	TX	0/15	
NONE_(HEALTHY_CONTROL)	MMI	3.75	Healthy Control	C2986479	[qlco]	["Healthy Control"-tx-1-"HEALTHY CONTROL"-noun-0]	TX	6/15	
HEALTHY_PATIENT  5
HEALTHY_PATIENT	MMI	6.83	Patients	C0030705	[podg]	["*^patient"-tx-1-"PATIENT"-noun-0]	TX	8/7	M01.643
HEALTHY_PATIENT	MMI	3.68	Abortion consent:Finding:Point in time:^Patient:Document	C2360836	[clna]	["Patient"-tx-1-"PATIENT"-noun-0]	TX	8/7	
HEALTHY_PATIENT	MMI	3.68	Hysterectomy consent:Finding:Point in time:^Patient:Document	C2360838	[clna]	["Patient"-tx-1-"PATIENT"-noun-0]	TX	8/7	
HEALTHY_PATIENT	MMI	3.68	Sterilization consent:Finding:Point in time:^Patient:Document	C2360840	[clna]	["Patient"-tx-1-"PATIENT"-noun-0]	TX	8/7	
HEALTHY_PATIENT	MMI	3.50	Healthy	C3898900	[qlco]	["Healthy"-tx-1-"HEALTHY"-adj-0]	TX	0/7	
HLD  0
LISSENCEPHALY_P>A  0
LIVER  6
LIVER	MMI	8.34	Liver	C0023884	[bpoc]	["LIVER"-tx-1-"LIVER"-noun-0]	TX	0/5	A03.620
LIVER	MMI	5.18	Entire liver	C1278929	[bpoc]	["Liver"-tx-1-"LIVER"-noun-0]	TX	0/5	
LIVER	MMI	5.18	Liver Flavor	C2346688	[food]	["LIVER"-tx-1-"LIVER"-noun-0]	TX	0/5	
LIVER	MMI	5.18	Liver parenchyma	C0736268	[bpoc]	["LIVER"-tx-1-"LIVER"-noun-0]	TX	0/5	
LIVER_CANCER	MMI	5.18	Liver and Intrahepatic Biliary Tract Carcinoma	C0279000	[neop]	["Liver Cancer"-tx-1-"LIVER CANCER"-noun-0]	TX	0/12	
LIVER_CANCER	MMI	5.18	Malignant neoplasm of liver	C0345904	[neop]	["Cancer, Liver"-tx-1-"LIVER CANCER"-noun-0]	TX	0/12	
LUAD  0
LUNG  17
LARGE_CELL_LUNG_CANCER	MMI	5.18	Large cell carcinoma of lung	C0345958	[neop]	["large cell lung cancer"-tx-1-"LARGE CELL LUNG CANCER"-noun-0]	TX	0/22	
LUNG_ADENOCARCINOMA	MMI	14.64	Adenocarcinoma of lung (disorder)	C0152013	[neop]	["Lung Adenocarcinoma"-tx-1-"LUNG ADENOCARCINOMA"-noun-0]	TX	0/19	x.x.x.x
LUNG	MMI	8.34	Lung	C0024109	[bpoc]	["LUNG"-tx-1-"LUNG"-noun-0]	TX	0/4	A04.411
LUNG	MMI	5.18	Entire lung	C1278908	[bpoc]	["Lung"-tx-1-"LUNG"-noun-0]	TX	0/4	
LUNG	MMI	5.18	Structure of parenchyma of lung	C0819757	[tisu]	["LUNG"-tx-1-"LUNG"-noun-0]	TX	0/4	
LUNG_CANCER	MMI	5.18	Carcinoma of lung	C0684249	[neop]	["-- Lung Cancer"-tx-1-"LUNG CANCER"-noun-0]	TX	0/11	
LUNG_CANCER	MMI	5.18	Malignant neoplasm of lung	C0242379	[neop]	["Lung Cancer"-tx-1-"LUNG CANCER"-noun-0]	TX	0/11	
LUNG_CANCER	MMI	5.18	Primary malignant neoplasm of lung	C1306460	[neop]	["Lung cancer"-tx-1-"LUNG CANCER"-noun-0]	TX	0/11	
LUNG_SARCOMATOID_CARCINOMA	MMI	5.18	Lung Sarcomatoid Carcinoma	C1708781	[neop]	["Lung Sarcomatoid Carcinoma"-tx-1-"LUNG SARCOMATOID CARCINOMA"-noun-0]	TX	0/26	
LUNG_SQUAMOUS_CELL_CARCINOMA	MMI	5.18	Squamous cell carcinoma of lung	C0149782	[neop]	["lung squamous cell carcinoma"-tx-1-"LUNG SQUAMOUS CELL CARCINOMA"-noun-0]	TX	0/28	
NON-SMALL_CELL_LUNG_CANCER	MMI	27.26	Non-Small Cell Lung Carcinoma	C0007131	[neop]	["Lung cancer, non-small cell"-tx-1-"NON-SMALL CELL LUNG CANCER"-noun-0]	TX	0/26	C04.588.894.797.520.109.220.249;C08.381.540.140.500;C08.785.520.100.220.500
NON-SMALL_CELL_LUNG_CANCER	MMI	5.18	NCI CTEP SDC Non-Small Cell Lung Cancer Sub-Category Terminology	C3539721	[inpr]	["Non-Small Cell Lung Cancer"-tx-1-"NON-SMALL CELL LUNG CANCER"-noun-0]	TX	0/26	
NON-SMALL_CELL_LUNG_CANCER	MMI	5.18	Non-Small Cell Lung Cancer Pathway	C2984258	[cnce]	["Non-small cell lung cancer"-tx-1-"NON-SMALL CELL LUNG CANCER"-noun-0]	TX	0/26	
SMALL_CELL_LUNG_CANCER	MMI	27.26	Small cell carcinoma of lung	C0149925	[neop]	["Lung cancer, small cell"-tx-1-"SMALL CELL LUNG CANCER"-noun-0]	TX	0/22	C04.588.894.797.520.109.220.624;C08.381.540.140.750;C08.785.520.100.220.750
SMALL_CELL_LUNG_CANCER	MMI	5.18	NCI CTEP SDC Small Cell Lung Cancer Sub-Category Terminology	C3540630	[inpr]	["Small Cell Lung Cancer"-tx-1-"SMALL CELL LUNG CANCER"-noun-0]	TX	0/22	
SMALL_CELL_LUNG_CANCER	MMI	5.18	Small Cell Lung Cancer Pathway	C2984312	[cnce]	["Small cell lung cancer"-tx-1-"SMALL CELL LUNG CANCER"-noun-0]	TX	0/22	
TRAUMATIC_WET_LUNG	MMI	5.18	Pulmonary insufficiency following trauma	C1368020	[dsyn]	["Traumatic wet lung"-tx-1-"TRAUMATIC WET LUNG"-noun-0]	TX	0/18	
MATCHED_SKIN  5
MATCHED_SKIN	MMI	6.83	Skin	C1123023	[bdsy]	["SKIN"-tx-1-"SKIN"-noun-0]	TX	8/4	A17.815
MATCHED_SKIN	MMI	3.68	Entire skin	C1278993	[bdsy]	["Skin"-tx-1-"SKIN"-noun-0]	TX	8/4	
MATCHED_SKIN	MMI	3.68	Skin Specimen	C0444099	[bdsu]	["Skin"-tx-1-"SKIN"-noun-0]	TX	8/4	
MATCHED_SKIN	MMI	3.50	MATCHING	C0150103	[resa]	["matched"-tx-1-"MATCHED"-adj-0]	TX	0/7	
MATCHED_SKIN	MMI	3.50	Match	C1708943	[qlco]	["Matched"-tx-1-"MATCHED"-adj-0]	TX	0/7	
MDS  7
AML_WITH_MDS-RELATED_CHANGES	MMI	3.67	Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome	C1332153	[neop]	["AML/MDS"-tx-1-"AML MDS"-noun-0]	TX	0/3,9/3	
AML_WITH_MDS-RELATED_CHANGES	MMI	3.46	Changed status	C0443172	[qnco]	["changes"-tx-1-"CHANGES"-noun-0]	TX	21/7	
AML_WITH_MDS-RELATED_CHANGES	MMI	3.46	Changing	C0392747	[ftcn]	["changes"-tx-1-"CHANGES"-noun-0]	TX	21/7	
AML_WITH_MDS-RELATED_CHANGES	MMI	3.46	Related personal status	C0445223	[fndg]	["Related"-tx-1-"RELATED"-adj-0]	TX	13/7	
AML_WITH_MDS-RELATED_CHANGES	MMI	3.46	Relationships	C0439849	[qlco]	["Related"-tx-1-"RELATED"-adj-0]	TX	13/7	
MDS	MMI	5.18	SF3B1 wt Allele	C3273937	[gngm]	["MDS"-tx-1-"MDS"-noun-0]	TX	0/3	
MDS	MMI	5.18	YWHAE wt Allele	C3539662	[gngm]	["MDS"-tx-1-"MDS"-noun-0]	TX	0/3	
MS  16
ARMS	MMI	24.11	Alveolar rhabdomyosarcoma	C0206655	[neop]	["ARMS"-tx-1-"ARMS"-noun-0]	TX	0/4	C04.557.450.590.550.660.665;C04.557.450.795.550.660.665
ARMS	MMI	14.64	Upper arm	C0446516	[blor]	["Arms"-tx-1-"ARMS"-noun-0]	TX	0/4	A01.378.800.075
ARMS	MMI	5.18	AKR1A1 wt Allele	C3715044	[gngm]	["ARM"-tx-1-"ARMS"-noun-0]	TX	0/4	
ARMS	MMI	5.18	Entire upper arm	C1269612	[bpoc]	["Arm"-tx-1-"ARMS"-noun-0]	TX	0/4	
ARMS	MMI	5.18	Entire upper limb	C1269078	[bpoc]	["Arm"-tx-1-"ARMS"-noun-0]	TX	0/4	
ARMS	MMI	5.18	KIDINS220 gene	C2681631	[gngm]	["ARMS"-tx-1-"ARMS"-noun-0]	TX	0/4	
ERMS	MMI	24.11	Rhabdomyosarcoma, Embryonal	C0206656	[neop]	["ERMS"-tx-1-"ERMS"-noun-0]	TX	0/4	C04.557.450.590.550.660.675;C04.557.450.795.550.660.675
ERMS	MMI	5.18	ETS Translocation Variant 5	C3273435	[aapp]	["ERM"-tx-1-"ERMS"-noun-0]	TX	0/4	
ERMS	MMI	5.18	ETV5 gene	C1414477	[gngm]	["ERM"-tx-1-"ERMS"-noun-0]	TX	0/4	
ERMS	MMI	5.18	ETV5 wt Allele	C3273434	[gngm]	["ERM"-tx-1-"ERMS"-noun-0]	TX	0/4	
MS	MMI	20.95	5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase	C0039676	[aapp,enzy]	["MS"-tx-1-"MS"-noun-0]	TX	0/2	D08.811.913.555.500.645
MS	MMI	5.18	MTR wt Allele	C3539704	[gngm]	["MS"-tx-1-"MS"-noun-0]	TX	0/2	
MS	MMI	5.18	Ms. - Title	C2349943	[cnce]	["Ms."-tx-1-"MS"-noun-0]	TX	0/2	
MULTIPLE_SCLEROSIS	MMI	5.18	MS gene	C1417325	[gngm]	["multiple sclerosis"-tx-1-"MULTIPLE SCLEROSIS"-noun-0]	TX	0/18	
ROTHMUND-THOMSON_SYNDROME	MMI	14.64	Rothmund-Thomson syndrome	C0032339	[dsyn]	["ROTHMUND-THOMSON SYNDROME"-tx-1-"ROTHMUND-THOMSON SYNDROME"-noun-0]	TX	0/25	C16.131.831.775;C16.320.850.765;C16.614.760;C17.800.804.775;C17.800.827.775;C18.452.284.760
RRMS	MMI	3.98	RNA Recognition Motif	C1522002	[aapp,bacs]	["RRM"-tx-1-"RRMS"-noun-0]	TX	0/4	
NA  38
ANAPLASTIC_THYROID_CANCER	MMI	17.80	Anaplastic thyroid carcinoma	C0238461	[neop]	["Anaplastic Thyroid Cancer"-tx-1-"ANAPLASTIC THYROID CANCER"-noun-0]	TX	0/25	C04.557.470.200.725
EMBRYONAL_CARCINOMA	MMI	14.64	Embryonal Carcinoma	C0206659	[neop]	["Carcinoma, Embryonal"-tx-1-"EMBRYONAL CARCINOMA"-noun-0]	TX	0/19	C04.557.465.200
EXTRANODAL_MARGINAL_ZONE_LYMPHOMA	MMI	22.73	Marginal Zone B-Cell Lymphoma	C1367654	[neop]	["Marginal Zone Lymphoma"-tx-1-"MARGINAL ZONE LYMPHOMA"-noun-0]	TX	11/22	C04.557.386.480.150.570;C15.604.515.569.480.150.570;C20.683.515.761.480.150.570
EXTRANODAL_MARGINAL_ZONE_LYMPHOMA	MMI	22.73	Mucosa-Associated Lymphoid Tissue Lymphoma	C0242647	[neop]	["marginal zone lymphoma"-tx-1-"MARGINAL ZONE LYMPHOMA"-noun-0]	TX	11/22	C04.557.386.480.150.570;C15.604.515.569.480.150.570;C20.683.515.761.480.150.570
EXTRANODAL_MARGINAL_ZONE_LYMPHOMA	MMI	3.47	Extranodal	C1517067	[spco]	["Extranodal"-tx-1-"EXTRANODAL"-adj-0]	TX	0/10	
GESTATIONAL_DIABETES_MELLITUS	MMI	17.80	Gestational Diabetes	C0085207	[patf]	["DIABETES MELLITUS, GESTATIONAL"-tx-1-"GESTATIONAL DIABETES MELLITUS"-noun-0]	TX	0/29	C13.703.170;C18.452.394.750.448;C19.246.200
HYPOMYELINATING_LEUKODYSTROPHY	MMI	5.18	Leukodystrophy, hypomyelinating	C2677112	[fndg]	["Leukodystrophy, hypomyelinating"-tx-1-"HYPOMYELINATING LEUKODYSTROPHY"-noun-0]	TX	0/30	
LUMINAL_BREAST_CANCER	MMI	13.22	Breast Carcinoma	C0678222	[neop]	["Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	8/13	C04.588.180;C17.800.090.500
LUMINAL_BREAST_CANCER	MMI	3.75	Malignant neoplasm of breast	C0006142	[neop]	["-- Breast Cancer"-tx-1-"BREAST CANCER"-noun-0]	TX	8/13	
LUMINAL_BREAST_CANCER	MMI	3.48	Luminal region	C0524462	[spco]	["Luminal"-tx-1-"LUMINAL"-adj-0]	TX	0/7	
MALIGNANT_MELANOMA	MMI	20.95	melanoma	C0025202	[neop]	["MALIGNANT MELANOMA"-tx-1-"MALIGNANT MELANOMA"-noun-0]	TX	0/18	C04.557.465.625.650.510;C04.557.580.625.650.510;C04.557.665.510
MALIGNANT_MELANOMA	MMI	14.64	Cutaneous Melanoma	C0151779	[neop]	["MELANOMA, MALIGNANT"-tx-1-"MALIGNANT MELANOMA"-noun-0]	TX	0/18	x.x.x.x
NASOPHARYNGEAL_CARCINOMA	MMI	14.64	Nasopharyngeal carcinoma	C2931822	[neop]	["NASOPHARYNGEAL CARCINOMA"-tx-1-"NASOPHARYNGEAL CARCINOMA"-noun-0]	TX	0/24	x.x.x.x
NA	MMI	5.18	No Application Type	C1546968	[idcn]	["NA"-tx-1-"NA"-noun-0]	TX	0/2	
NA	MMI	5.18	Not Applicable	C1272460	[qlco]	["{NA}"-tx-1-"NA"-noun-0]	TX	0/2	
NA	MMI	5.18	Package Type Not Applicable	C4049872	[ftcn]	["NA"-tx-1-"NA"-noun-0]	TX	0/2	
NA	MMI	5.18	Sodium Cation	C0597484	[elii]	["Na+"-tx-1-"NA"-noun-0]	TX	0/2	
NODAL_MARGINAL_ZONE_LYMPHOMA	MMI	24.11	Mucosa-Associated Lymphoid Tissue Lymphoma	C0242647	[neop]	["Nodal marginal zone lymphoma"-tx-1-"NODAL MARGINAL ZONE LYMPHOMA"-noun-0]	TX	0/28	C04.557.386.480.150.570;C15.604.515.569.480.150.570;C20.683.515.761.480.150.570
NODAL_MARGINAL_ZONE_LYMPHOMA	MMI	5.18	Monocytoid B-cell lymphoma	C0855139	[neop]	["Nodal Marginal Zone Lymphoma"-tx-1-"NODAL MARGINAL ZONE LYMPHOMA"-noun-0]	TX	0/28	
NON-MALIGNANT_TISSUE	MMI	3.63	Body tissue	C0040300	[tisu]	["TISSUE"-tx-1-"TISSUE"-noun-0]	TX	14/6	A10
NON-MALIGNANT_TISSUE	MMI	3.63	Tissue Specimen Code	C1547928	[inpr]	["Tissue"-tx-1-"TISSUE"-noun-0]	TX	14/6	
NON-MALIGNANT_TISSUE	MMI	3.53	Non-Malignant	C1518371	[qlco]	["Non-Malignant"-tx-1-"NON-MALIGNANT"-adj-0]	TX	0/13	
PULMONARY_HYPERTENSION	MMI	11.49	Pulmonary Hypertension	C0020542	[patf]	["Hypertension, pulmonary"-tx-1-"PULMONARY HYPERTENSION"-noun-0]	TX	0/22	C08.381.423
PULMONARY_HYPERTENSION	MMI	5.18	Pulmonary Hypertension Adverse Event	C1963220	[fndg]	["Pulmonary hypertension"-tx-1-"PULMONARY HYPERTENSION"-noun-0]	TX	0/22	
RENAL_CELL_ADENOCARCINOMA	MMI	20.95	Renal Cell Carcinoma	C0007134	[neop]	["Adenocarcinoma, Renal Cell"-tx-1-"RENAL CELL ADENOCARCINOMA"-noun-0]	TX	0/25	C04.557.470.200.025.390;C04.588.945.947.535.160;C12.758.820.750.160;C12.777.419.473.160;C13.351.937.820.535.160;C13.351.968.419.473.160
RPL	MMI	5.18	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 1	C3280670	[fndg]	["RPL"-tx-1-"RPL"-noun-0]	TX	0/3	
RRMS	MMI	3.98	RNA Recognition Motif	C1522002	[aapp,bacs]	["RRM"-tx-1-"RRMS"-noun-0]	TX	0/4	
SPLENIC_MARGINAL_ZONE_LYMPHOMA	MMI	5.18	Splenic Marginal Zone B-Cell Lymphoma	C0349632	[neop]	["Splenic Marginal Zone Lymphoma"-tx-1-"SPLENIC MARGINAL ZONE LYMPHOMA"-noun-0]	TX	0/30	
STABLE_ANGINA_PECTORIS	MMI	24.11	Stable angina	C0340288	[dsyn]	["Angina Pectoris, Stable"-tx-1-"STABLE ANGINA PECTORIS"-noun-0]	TX	0/22	C10.597.617.192.500.575;C14.280.647.187.362;C14.907.585.187.362;C23.888.592.612.233.500.575
SYSTEMIC_ANAPHYLACTIC_SHOCK	MMI	13.22	anaphylaxis	C0002792	[patf]	["ANAPHYLACTIC SHOCK"-tx-1-"ANAPHYLACTIC SHOCK"-noun-0]	TX	9/18	C20.543.480.099
SYSTEMIC_ANAPHYLACTIC_SHOCK	MMI	3.48	Systemic	C0205373	[ftcn]	["Systemic"-tx-1-"SYSTEMIC"-adj-0]	TX	0/8	
TERMINAL_HEART_FAILURE	MMI	10.06	Heart failure	C0018801	[dsyn]	["Failure, Heart"-tx-1-"HEART FAILURE"-noun-0]	TX	9/13	C14.280.434
TERMINAL_HEART_FAILURE	MMI	3.75	Congestive heart failure	C0018802	[dsyn]	["Heart Failure"-tx-1-"HEART FAILURE"-noun-0]	TX	9/13	
TERMINAL_HEART_FAILURE	MMI	3.48	End-stage	C0205088	[qlco]	["Terminal"-tx-1-"TERMINAL"-adj-0]	TX	0/8	
TERMINAL_HEART_FAILURE	MMI	3.48	Terminal (end postition)	C1705315	[spco]	["Terminal"-tx-1-"TERMINAL"-adj-0]	TX	0/8	
TERMINAL_HEART_FAILURE	MMI	3.48	Terminal Device Component	C1705314	[mnob]	["Terminal"-tx-1-"TERMINAL"-adj-0]	TX	0/8	
UNAFFECTED	MMI	5.18	Unaffected	C2986417	[cnce]	["Unaffected"-tx-1-"UNAFFECTED"-adj-0]	TX	0/10	
UNSTABLE_ANGINA_PECTORIS	MMI	24.11	Angina, Unstable	C0002965	[dsyn]	["Angina Pectoris, Unstable"-tx-1-"UNSTABLE ANGINA PECTORIS"-noun-0]	TX	0/24	C10.597.617.192.500.150;C14.280.647.187.150;C14.907.585.187.150;C23.888.592.612.233.500.150
NAIVE  0
NEPHRONOPHTHESIS  0
NO  182
ACUTE_GANGRENOUS_APPENDICITIS	MMI	5.18	Acute gangrenous appendicitis	C0267625	[dsyn]	["Acute gangrenous appendicitis"-tx-1-"ACUTE GANGRENOUS APPENDICITIS"-noun-0]	TX	0/29	
ACUTE_MONOCYTIC_LEUKEMIA	MMI	20.95	Acute monocytic leukemia	C0023465	[neop]	["Acute monocytic leukaemia"-tx-1-"ACUTE MONOCYTIC LEUKEMIA"-noun-0]	TX	0/24	C04.557.337.539.275.484
ACUTE_MONOCYTIC_LEUKEMIA	MMI	5.18	M5b Acute differentiated monocytic leukemia	C1318544	[neop]	["Acute Monocytic Leukemia"-tx-1-"ACUTE MONOCYTIC LEUKEMIA"-noun-0]	TX	0/24	
ACUTE_MYELOGENOUS_LEUKEMIA	MMI	17.80	Leukemia, Myelocytic, Acute	C0023467	[neop]	["Acute myelogenous leukaemia"-tx-1-"ACUTE MYELOGENOUS LEUKEMIA"-noun-0]	TX	0/26	C04.557.337.539.275
ACUTE_MYELOMONOCYTIC_LEUKEMIA	MMI	17.80	Acute myelomonocytic leukemia	C0023479	[neop]	["Acute myelomonocytic leukaemia"-tx-1-"ACUTE MYELOMONOCYTIC LEUKEMIA"-noun-0]	TX	0/29	C04.557.337.539.520
ACUTE_PHLEGMONOUS_APPENDICITIS	MMI	16.40	Appendicitis	C0003615	[dsyn]	["Acute Appendicitis"-tx-1-"ACUTE APPENDICITIS"-noun-0]	TX	0/5,18/12	C01.539.463.099;C06.405.205.099;C06.405.469.110.207
ACUTE_PHLEGMONOUS_APPENDICITIS	MMI	3.78	Acute appendicitis NOS (disorder)	C0085693	[dsyn]	["APPENDICITIS, ACUTE"-tx-1-"ACUTE APPENDICITIS"-noun-0]	TX	0/5,18/12	
ACUTE_PHLEGMONOUS_APPENDICITIS	MMI	3.48	Phlegmonous	C0443278	[ftcn]	["Phlegmonous"-tx-1-"PHLEGMONOUS"-adj-0]	TX	6/11	
ACUTE_SIMPLE_APPENDICITIS	MMI	3.78	Acute appendicitis NOS (disorder)	C0085693	[dsyn]	["APPENDICITIS, ACUTE"-tx-1-"ACUTE APPENDICITIS"-noun-0]	TX	0/5,13/12	
ADAMANTINOMATOUS_CRANIOPHARYNGIOMA	MMI	17.80	Adamantinous Craniopharyngioma	C0431129	[neop]	["Adamantinomatous Craniopharyngioma"-tx-1-"ADAMANTINOMATOUS CRANIOPHARYNGIOMA"-noun-0]	TX	0/34	C04.557.465.625.200;C04.557.580.625.200
ADENOCARCINOMA	MMI	17.80	Adenocarcinoma	C0001418	[neop]	["ADENOCARCINOMA"-tx-1-"ADENOCARCINOMA"-noun-0]	TX	0/14	C04.557.470.200.025
ADENOMYOEPITHELIOMA_OF_THE_BREAST	MMI	5.18	Breast Adenomyoepithelioma	C1510795	[neop]	["Adenomyoepithelioma of the Breast"-tx-1-"ADENOMYOEPITHELIOMA OF THE BREAST"-noun-0]	TX	0/33	
ANOXIA	MMI	14.64	Anoxia	C0003130	[patf]	["ANOXIA"-tx-1-"ANOXIA"-noun-0]	TX	0/6	C23.888.852.079
ANOXIA	MMI	5.18	Anoxia <insect>	C3888241	[euka]	["Anoxia"-tx-1-"ANOXIA"-noun-0]	TX	0/6	
B-ALL_NOS	MMI	24.11	Burkitt Lymphoma	C0006413	[neop]	["b-all"-tx-1-"B-ALL"-noun-0]	TX	0/5	C02.256.466.313.165;C02.928.313.165;C04.557.386.480.150.165;C15.604.515.569.480.150.165;C20.683.515.761.480.150.165
B-ALL_NOS	MMI	5.18	Precursor B-cell lymphoblastic leukemia	C1292769	[neop]	["B-ALL"-tx-1-"B-ALL"-noun-0]	TX	0/5	
BIPHENOTYPIC_B_MYELOMONOCYTIC_LEUKEMIA	MMI	3.68	Myelomonocytic leukemia	C0027019	[neop]	["Myelomonocytic leukemia"-tx-1-"MYELOMONOCYTIC LEUKEMIA"-noun-0]	TX	15/23	
BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	9.99	Bone Marrow Cells	C0005955	[cell]	["Bone Marrow Cells"-tx-1-"BONE MARROW CELLS"-noun-0]	TX	0/17	A11.148;A15.378.316
BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	3.76	Encounter for being a bone marrow donor	C1313934	[fndg]	["Bone marrow donors"-tx-1-"BONE MARROW DONORS"-noun-0]	TX	0/11,31/6	
BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	3.60	Cells	C0007634	[cell]	["Cells"-tx-1-"CELLS"-noun-0]	TX	12/5	A11
BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	3.60	Cells [Chemical/Ingredient]	C3282337	[cell]	["Cells"-tx-1-"CELLS"-noun-0]	TX	12/5	
BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	3.46	Donor person	C0013018	[popg]	["Donors"-tx-1-"DONORS"-noun-0]	TX	31/6	
BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	3.46	Encounter due to being a donor	C1527169	[fndg]	["Donors"-tx-1-"DONORS"-noun-0]	TX	31/6	
BONE_MARROW_CELLS_FROM_HEALTHY_DONORS	MMI	3.46	Healthy	C3898900	[qlco]	["Healthy"-tx-1-"HEALTHY"-adj-0]	TX	23/7	
BREAST_ADENOCARCINOMA	MMI	5.18	breast adenocarcinoma	C0858252	[neop]	["Breast Adenocarcinoma"-tx-1-"BREAST ADENOCARCINOMA"-noun-0]	TX	0/21	
BREAST_CARCINOMA	MMI	14.64	Breast Carcinoma	C0678222	[neop]	["BREAST CARCINOMA"-tx-1-"BREAST CARCINOMA"-noun-0]	TX	0/16	C04.588.180;C17.800.090.500
BREAST_CARCINOMA	MMI	5.18	Malignant neoplasm of breast	C0006142	[neop]	["Breast Carcinoma"-tx-1-"BREAST CARCINOMA"-noun-0]	TX	0/16	
BREAST_DUCTAL_CARCINOMA	MMI	24.11	Mammary Ductal Carcinoma	C0021367	[neop]	["breast ductal carcinoma"-tx-1-"BREAST DUCTAL CARCINOMA"-noun-0]	TX	0/23	C04.557.470.200.025.232.500;C04.557.470.615.132.500;C04.588.180.390;C17.800.090.500.390
CARCINOMA	MMI	14.64	Carcinoma	C0007097	[neop]	["CARCINOMA"-tx-1-"CARCINOMA"-noun-0]	TX	0/9	C04.557.470.200
CARCINOMA_HEPATOCELLULAR	MMI	13.14	Carcinoma	C0007097	[neop]	["CARCINOMA"-tx-1-"CARCINOMA"-noun-0]	TX	0/9	C04.557.470.200
CARCINOMA_HEPATOCELLULAR	MMI	3.50	Hepatocellular	C2697585	[qlco]	["Hepatocellular"-tx-1-"HEPATOCELLULAR"-adj-0]	TX	10/14	
CERVICAL_ADENOCARCINOMA	MMI	5.18	Cervical Adenocarcinoma	C0279672	[neop]	["Cervical Adenocarcinoma"-tx-1-"CERVICAL ADENOCARCINOMA"-noun-0]	TX	0/23	
CHOLANGIOCARCINOMA	MMI	20.95	Cholangiocarcinoma	C0206698	[neop]	["Cholangiocarcinoma"-tx-1-"CHOLANGIOCARCINOMA"-noun-0]	TX	0/18	C04.557.470.200.025.450
CHRONIC_MYELOGENOUS_LEUKEMIA	MMI	17.80	Myeloid Leukemia, Chronic	C0023473	[neop]	["Chronic myelogenous leukaemia"-tx-1-"CHRONIC MYELOGENOUS LEUKEMIA"-noun-0]	TX	0/28	C04.557.337.539.250;C15.378.190.636.370
COLON_CARCINOMA,_HNPCC	MMI	12.94	MLH1 protein, human	C0252642	[aapp,bacs]	["HNPCC"-tx-1-"HNPCC"-noun-0]	TX	17/5	x.x.x.x
COLON_CARCINOMA,_HNPCC	MMI	3.75	Colon Carcinoma	C0699790	[neop]	["COLON CARCINOMA"-tx-1-"COLON CARCINOMA"-noun-0]	TX	0/15	
COLON_CARCINOMA,_PRIMARY	MMI	16.09	Colon structure (body structure)	C0009368	[bpoc]	["COLON"-tx-1-"COLON"-noun-0]	TX	0/5	A03.556.124.526.356;A03.556.249.249.356
COLON_CARCINOMA,_PRIMARY	MMI	3.78	Primary Carcinoma	C1335475	[neop]	["Primary Carcinoma"-tx-1-"CARCINOMA PRIMARY"-noun-0]	TX	6/9,17/7	
COLON_CARCINOMA,_PRIMARY	MMI	3.75	Colon Carcinoma	C0699790	[neop]	["COLON CARCINOMA"-tx-1-"COLON CARCINOMA"-noun-0]	TX	0/15	
COLON_CARCINOMA,_PRIMARY	MMI	3.48	Colon <insect>	C3888384	[euka]	["Colon"-tx-1-"COLON"-noun-0]	TX	0/5	
COLON_CARCINOMA,_PRIMARY	MMI	3.48	Entire colon	C1281569	[bpoc]	["Colon"-tx-1-"COLON"-noun-0]	TX	0/5	
COLON_CARCINOMA,_PRIMARY	MMI	3.48	Primary	C0205225	[qlco]	["Primary"-tx-1-"PRIMARY"-adj-0]	TX	17/7	
COLON_CARCINOMA,_PRIMARY	MMI	3.48	Primary operation	C0439631	[topp]	["Primary"-tx-1-"PRIMARY"-adj-0]	TX	17/7	
COLON_CARCINOMA,_PRIMARY	MMI	3.48	True primary (qualifier value)	C0439612	[tmco]	["Primary"-tx-1-"PRIMARY"-adj-0]	TX	17/7	
COLON_CARCINOMA,_SPORADIC	MMI	3.75	Colon Carcinoma	C0699790	[neop]	["COLON CARCINOMA"-tx-1-"COLON CARCINOMA"-noun-0]	TX	0/15	
COLON_CARCINOMA,_SPORADIC	MMI	3.48	Isolated cases	C1853237	[fndg]	["Sporadic"-tx-1-"SPORADIC"-adj-0]	TX	17/8	
COLON_CARCINOMA,_SPORADIC	MMI	3.48	Sporadic (qualifier value)	C0205422	[tmco]	["Sporadic"-tx-1-"SPORADIC"-adj-0]	TX	17/8	
COLON_CARCINOMA	MMI	5.18	Colon Carcinoma	C0699790	[neop]	["COLON CARCINOMA"-tx-1-"COLON CARCINOMA"-noun-0]	TX	0/15	
COLORECTAL_ADENOCARCINOMA	MMI	5.18	Adenocarcinoma of large intestine	C1319315	[neop]	["Colorectal Adenocarcinoma"-tx-1-"COLORECTAL ADENOCARCINOMA"-noun-0]	TX	0/25	
COLORECTAL_CARCINOMA	MMI	20.95	Colorectal Carcinoma	C0009402	[neop]	["Colorectal Carcinoma"-tx-1-"COLORECTAL CARCINOMA"-noun-0]	TX	0/20	C04.588.274.476.411.307;C06.301.371.411.307;C06.405.249.411.307;C06.405.469.158.356;C06.405.469.491.307;C06.405.469.860.180
DLBCL_NOS	MMI	24.11	Diffuse Large B-Cell Lymphoma	C0079744	[neop]	["DLBCL"-tx-1-"DLBCL"-noun-0]	TX	0/5	C04.557.386.480.150.585;C15.604.515.569.480.150.585;C20.683.515.761.480.150.585
DUCTAL_CARCINOMA	MMI	20.95	Ductal Carcinoma	C1176475	[neop]	["Ductal Carcinoma"-tx-1-"DUCTAL CARCINOMA"-noun-0]	TX	0/16	C04.557.470.200.025.232;C04.557.470.615.132
DUCTAL_CARCINOMA	MMI	5.18	Ductal Breast Carcinoma	C1527349	[neop]	["Ductal Carcinoma"-tx-1-"DUCTAL CARCINOMA"-noun-0]	TX	0/16	
EMBRYONAL_CARCINOMA	MMI	14.64	Embryonal Carcinoma	C0206659	[neop]	["Carcinoma, Embryonal"-tx-1-"EMBRYONAL CARCINOMA"-noun-0]	TX	0/19	C04.557.465.200
ENDOMETRIAL_ADENOCARCINOMA	MMI	5.18	Endometrial adenocarcinoma	C1153706	[neop]	["Endometrial Adenocarcinoma"-tx-1-"ENDOMETRIAL ADENOCARCINOMA"-noun-0]	TX	0/26	
ENDOMETRIAL_CARCINOMA	MMI	20.95	Endometrial Carcinoma	C0476089	[neop]	["ENDOMETRIAL CARCINOMA"-tx-1-"ENDOMETRIAL CARCINOMA"-noun-0]	TX	0/21	C04.588.945.418.948.585;C13.351.500.852.762.200;C13.351.937.418.875.200
EOSINOPHILIA	MMI	14.64	Eosinophilia	C0014457	[dsyn]	["EOSINOPHILIA"-tx-1-"EOSINOPHILIA"-noun-0]	TX	0/12	C15.378.553.231
EOSINOPHILIA	MMI	5.18	Eosinophil count raised (finding)	C2240374	[lbtr]	["Eosinophilia"-tx-1-"EOSINOPHILIA"-noun-0]	TX	0/12	
EOSINOPHILIA	MMI	5.18	Eosinophilic disorder	C1306759	[dsyn]	["Eosinophilia"-tx-1-"EOSINOPHILIA"-noun-0]	TX	0/12	
ESOPHAGEAL_ADENOCARCINOMA	MMI	14.64	Adenocarcinoma Of Esophagus	C0279628	[neop]	["Oesophageal Adenocarcinoma NOS"-tx-1-"ESOPHAGEAL ADENOCARCINOMA"-noun-0]	TX	0/25	x.x.x.x
ESOPHAGEAL_SQUAMOUS_CELL_CARCINOMA	MMI	14.64	Squamous cell carcinoma of esophagus	C0279626	[neop]	["Esophageal Squamous Cell Carcinoma"-tx-1-"ESOPHAGEAL SQUAMOUS CELL CARCINOMA"-noun-0]	TX	0/34	x.x.x.x
EXTRANODAL_MARGINAL_ZONE_LYMPHOMA	MMI	22.73	Marginal Zone B-Cell Lymphoma	C1367654	[neop]	["Marginal Zone Lymphoma"-tx-1-"MARGINAL ZONE LYMPHOMA"-noun-0]	TX	11/22	C04.557.386.480.150.570;C15.604.515.569.480.150.570;C20.683.515.761.480.150.570
EXTRANODAL_MARGINAL_ZONE_LYMPHOMA	MMI	22.73	Mucosa-Associated Lymphoid Tissue Lymphoma	C0242647	[neop]	["marginal zone lymphoma"-tx-1-"MARGINAL ZONE LYMPHOMA"-noun-0]	TX	11/22	C04.557.386.480.150.570;C15.604.515.569.480.150.570;C20.683.515.761.480.150.570
EXTRANODAL_MARGINAL_ZONE_LYMPHOMA	MMI	3.47	Extranodal	C1517067	[spco]	["Extranodal"-tx-1-"EXTRANODAL"-adj-0]	TX	0/10	
FIBROSIS_(NON-SARCOIDOSIS)	MMI	12.94	Sarcoidosis	C0036202	[dsyn]	["SARCOIDOSIS"-tx-1-"SARCOIDOSIS"-adj-1]	TX	14/11	C15.604.515.827
FIBROSIS_(NON-SARCOIDOSIS)	MMI	9.94	Fibrosis	C0016059	[patf]	["FIBROSIS"-tx-1-"FIBROSIS"-noun-1]	TX	0/8	C23.550.355
FIBROSIS_(NON-SARCOIDOSIS)	MMI	3.48	Negation	C1518422	[ftcn]	["Non"-tx-1-"NON"-adj-0]	TX	10/3	
FIBROSIS_(NON-SARCOIDOSIS)	MMI	3.48	SARCOIDOSIS, SUSCEPTIBILITY TO, 1 (finding)	C2697310	[fndg]	["SARCOIDOSIS"-tx-1-"SARCOIDOSIS"-adj-1]	TX	14/11	
HCV_INFECTION	MMI	9.99	Communicable Diseases	C0009450	[dsyn]	["Infection, NOS"-tx-1-"INFECTION"-noun-0]	TX	4/9	C01.539.221
HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA	MMI	13.33	Squamous cell carcinoma of the head and neck	C1168401	[neop]	["head neck Squamous Cell Carcinoma"-tx-1-"HEAD NECK SQUAMOUS CELL CARCINOMA"-noun-0]	TX	0/4,9/28	x.x.x.x
HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA	MMI	3.86	NCI CTEP SDC Head and Neck Squamous Cell Carcinoma Sub-Category Terminology	C3538931	[inpr]	["head neck Squamous Cell Carcinoma"-tx-1-"HEAD NECK SQUAMOUS CELL CARCINOMA"-noun-0]	TX	0/4,9/28	
HEPATOCELLULAR_CARCINOMA	MMI	20.95	Liver carcinoma	C2239176	[neop]	["HEPATOCELLULAR CARCINOMA"-tx-1-"HEPATOCELLULAR CARCINOMA"-noun-0]	TX	0/24	C04.557.470.200.025.255;C04.588.274.623.160;C06.301.623.160;C06.552.697.160
HUMAN_IMMUNODEFICIENCY_VIRUS_INFECTIOUS_DISEASE	MMI	16.45	HIV Infections	C0019693	[dsyn]	["Human immunodeficiency virus disease"-tx-1-"HUMAN IMMUNODEFICIENCY VIRUS DISEASE"-noun-0]	TX	0/28,40/7	C02.782.815.616.400;C02.800.801.400;C20.673.480
HUMAN_IMMUNODEFICIENCY_VIRUS_INFECTIOUS_DISEASE	MMI	9.84	Communicable Diseases	C0009450	[dsyn]	["Infection, NOS"-tx-1-"INFECTIOUS"-noun-0]	TX	29/10	C01.539.221
HUMAN_IMMUNODEFICIENCY_VIRUS_INFECTIOUS_DISEASE	MMI	6.69	Infection	C3714514	[patf]	["Infections"-tx-1-"INFECTIOUS"-noun-0]	TX	29/10	C01.539
HYPERLIPIDEMIA	MMI	17.80	Hyperlipidemia	C0020473	[dsyn]	["Hyperlipidaemia, NOS"-tx-1-"HYPERLIPIDEMIA"-noun-0]	TX	0/14	C18.452.584.500.500
HYPOPHARYNGEAL_SQUAMOUS_CELL_CARCINOMA	MMI	5.18	hypopharyngeal squamous cell carcinoma	C0280321	[neop]	["Hypopharyngeal Squamous Cell Carcinoma"-tx-1-"HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA"-noun-0]	TX	0/38	
H	MMI	5.18	H NOS Antibodies	C0369286	[aapp,imft]	["H NOS"-tx-1-"H"-noun-0]	TX	0/1	
JUVENILE_MYELOMONOCYTIC_LEUKEMIA	MMI	17.80	Juvenile Myelomonocytic Leukemia	C0349639	[neop]	["Juvenile myelomonocytic leukaemia"-tx-1-"JUVENILE MYELOMONOCYTIC LEUKEMIA"-noun-0]	TX	0/32	C04.557.337.539.525;C15.378.190.615.520
LUNG_ADENOCARCINOMA	MMI	14.64	Adenocarcinoma of lung (disorder)	C0152013	[neop]	["Lung Adenocarcinoma"-tx-1-"LUNG ADENOCARCINOMA"-noun-0]	TX	0/19	x.x.x.x
LUNG_SARCOMATOID_CARCINOMA	MMI	5.18	Lung Sarcomatoid Carcinoma	C1708781	[neop]	["Lung Sarcomatoid Carcinoma"-tx-1-"LUNG SARCOMATOID CARCINOMA"-noun-0]	TX	0/26	
LUNG_SQUAMOUS_CELL_CARCINOMA	MMI	5.18	Squamous cell carcinoma of lung	C0149782	[neop]	["lung squamous cell carcinoma"-tx-1-"LUNG SQUAMOUS CELL CARCINOMA"-noun-0]	TX	0/28	
MALIGNANT_MELANOMA	MMI	20.95	melanoma	C0025202	[neop]	["MALIGNANT MELANOMA"-tx-1-"MALIGNANT MELANOMA"-noun-0]	TX	0/18	C04.557.465.625.650.510;C04.557.580.625.650.510;C04.557.665.510
MALIGNANT_MELANOMA	MMI	14.64	Cutaneous Melanoma	C0151779	[neop]	["MELANOMA, MALIGNANT"-tx-1-"MALIGNANT MELANOMA"-noun-0]	TX	0/18	x.x.x.x
MELANOMA	MMI	20.95	melanoma	C0025202	[neop]	["MELANOMA"-tx-1-"MELANOMA"-noun-0]	TX	0/8	C04.557.465.625.650.510;C04.557.580.625.650.510;C04.557.665.510
MELANOMA	MMI	5.18	Melanoma Pathway	C2984289	[ftcn]	["Melanoma"-tx-1-"MELANOMA"-noun-0]	TX	0/8	
MELANOMA	MMI	5.18	NCI CTEP SDC Melanoma Sub-Category Terminology	C3539018	[inpr]	["Melanoma"-tx-1-"MELANOMA"-noun-0]	TX	0/8	
MERKEL_CELL_CARCINOMA	MMI	24.11	Merkel cell carcinoma	C0007129	[neop]	["Merkel Cell Carcinoma"-tx-1-"MERKEL CELL CARCINOMA"-noun-0]	TX	0/21	C02.256.721.150;C02.928.216;C04.557.465.625.650.240.325;C04.557.470.200.025.370.325;C04.557.580.625.650.240.325
METASTATIC_MELANOMA	MMI	5.18	Metastatic melanoma	C0278883	[neop]	["Metastatic Melanoma"-tx-1-"METASTATIC MELANOMA"-noun-0]	TX	0/19	
MYOEPITHELIAL_CARCINOMA_OF_SALIVARY_GLAND	MMI	3.85	Salivary gland carcinoma	C0948750	[neop]	["Carcinoma of Salivary Gland"-tx-1-"CARCINOMA OF SALIVARY GLAND"-noun-0]	TX	14/27	
MYOEPITHELIAL_CARCINOMA_OF_SALIVARY_GLAND	MMI	3.46	Myoepithelial	C1513794	[spco]	["Myoepithelial"-tx-1-"MYOEPITHELIAL"-adj-0]	TX	0/13	
NASOPHARYNGEAL_CARCINOMA	MMI	14.64	Nasopharyngeal carcinoma	C2931822	[neop]	["NASOPHARYNGEAL CARCINOMA"-tx-1-"NASOPHARYNGEAL CARCINOMA"-noun-0]	TX	0/24	x.x.x.x
NEOPLASTIC,_ESOPHAGEAL_SQUAMOUS_CELL_CARCINOMA	MMI	13.31	Squamous cell carcinoma of esophagus	C0279626	[neop]	["Esophageal Squamous Cell Carcinoma"-tx-1-"ESOPHAGEAL SQUAMOUS CELL CARCINOMA"-noun-0]	TX	12/34	x.x.x.x
NEOPLASTIC,_ESOPHAGEAL_SQUAMOUS_CELL_CARCINOMA	MMI	3.46	Neoplastic	C1709160	[qlco]	["Neoplastic"-tx-1-"NEOPLASTIC"-adj-0]	TX	0/10	
NEPHRONOPHTHISIS	MMI	5.18	Nephronophthisis	C0687120	[dsyn]	["Nephronophthisis"-tx-1-"NEPHRONOPHTHISIS"-noun-0]	TX	0/16	
NODAL_MARGINAL_ZONE_LYMPHOMA	MMI	24.11	Mucosa-Associated Lymphoid Tissue Lymphoma	C0242647	[neop]	["Nodal marginal zone lymphoma"-tx-1-"NODAL MARGINAL ZONE LYMPHOMA"-noun-0]	TX	0/28	C04.557.386.480.150.570;C15.604.515.569.480.150.570;C20.683.515.761.480.150.570
NODAL_MARGINAL_ZONE_LYMPHOMA	MMI	5.18	Monocytoid B-cell lymphoma	C0855139	[neop]	["Nodal Marginal Zone Lymphoma"-tx-1-"NODAL MARGINAL ZONE LYMPHOMA"-noun-0]	TX	0/28	
NON-CF	MMI	16.30	Congo	C0009738	[geoa]	["CF"-tx-1-"CF"-adj-0]	TX	4/2	Z01.058.290.100.140
NON-CF	MMI	3.68	CFTR wt Allele	C3811819	[gngm]	["CF"-tx-1-"CF"-adj-0]	TX	4/2	
NON-CF	MMI	3.68	Negation	C1518422	[ftcn]	["Non"-tx-1-"NON"-adj-0]	TX	0/3	
NON-DISEASED	MMI	3.68	Negation	C1518422	[ftcn]	["Non"-tx-1-"NON"-adj-0]	TX	0/3	
NON-LS_SARCOIDOSIS	MMI	13.09	Sarcoidosis	C0036202	[dsyn]	["SARCOIDOSIS"-tx-1-"SARCOIDOSIS"-noun-1]	TX	7/11	C15.604.515.827
NON-LS_SARCOIDOSIS	MMI	9.78	Liechtenstein	C0023668	[geoa]	["LS"-tx-1-"LS"-noun-0]	TX	4/2	Z01.542.524
NON-LS_SARCOIDOSIS	MMI	3.63	SARCOIDOSIS, SUSCEPTIBILITY TO, 1 (finding)	C2697310	[fndg]	["SARCOIDOSIS"-tx-1-"SARCOIDOSIS"-noun-1]	TX	7/11	
NON-LS_SARCOIDOSIS	MMI	3.48	Negation	C1518422	[ftcn]	["Non"-tx-1-"NON"-noun-0]	TX	0/3	
NON-MALIGNANT_TISSUE	MMI	3.63	Body tissue	C0040300	[tisu]	["TISSUE"-tx-1-"TISSUE"-noun-0]	TX	14/6	A10
NON-MALIGNANT_TISSUE	MMI	3.63	Tissue Specimen Code	C1547928	[inpr]	["Tissue"-tx-1-"TISSUE"-noun-0]	TX	14/6	
NON-MALIGNANT_TISSUE	MMI	3.53	Non-Malignant	C1518371	[qlco]	["Non-Malignant"-tx-1-"NON-MALIGNANT"-adj-0]	TX	0/13	
NON-NEOPLASTIC	MMI	5.18	Non-Neoplastic Disorder	C1709246	[dsyn]	["NON-NEOPLASTIC"-tx-1-"NON-NEOPLASTIC"-adj-0]	TX	0/14	
NON-SIGNIFICANT_ATHEROSCLEROSIS	MMI	16.25	Atherosclerosis	C0004153	[dsyn]	["ATHEROSCLEROSIS"-tx-1-"ATHEROSCLEROSIS"-noun-1]	TX	16/15	C14.907.137.126.307
NON-SIGNIFICANT_ATHEROSCLEROSIS	MMI	13.09	Arteriosclerosis	C0003850	[dsyn]	["ATHEROSCLEROSIS"-tx-1-"ATHEROSCLEROSIS"-noun-1]	TX	16/15	C14.907.137.126
NON-SIGNIFICANT_ATHEROSCLEROSIS	MMI	3.48	Event Seriousness - Significant	C1546944	[qlco]	["Significant"-tx-1-"SIGNIFICANT"-adj-0]	TX	4/11	
NON-SIGNIFICANT_ATHEROSCLEROSIS	MMI	3.48	Negation	C1518422	[ftcn]	["Non"-tx-1-"NON"-adj-0]	TX	0/3	
NON-SIGNIFICANT_ATHEROSCLEROSIS	MMI	3.48	Significant	C0750502	[idcn]	["Significant"-tx-1-"SIGNIFICANT"-adj-0]	TX	4/11	
NON-SIGNIFICANT_ATHEROSCLEROSIS	MMI	3.48	Statistical Significance	C0237881	[qnco]	["significant"-tx-1-"SIGNIFICANT"-adj-0]	TX	4/11	
NON-SMALL_CELL_LUNG_CANCER	MMI	27.26	Non-Small Cell Lung Carcinoma	C0007131	[neop]	["Lung cancer, non-small cell"-tx-1-"NON-SMALL CELL LUNG CANCER"-noun-0]	TX	0/26	C04.588.894.797.520.109.220.249;C08.381.540.140.500;C08.785.520.100.220.500
NON-SMALL_CELL_LUNG_CANCER	MMI	5.18	NCI CTEP SDC Non-Small Cell Lung Cancer Sub-Category Terminology	C3539721	[inpr]	["Non-Small Cell Lung Cancer"-tx-1-"NON-SMALL CELL LUNG CANCER"-noun-0]	TX	0/26	
NON-SMALL_CELL_LUNG_CANCER	MMI	5.18	Non-Small Cell Lung Cancer Pathway	C2984258	[cnce]	["Non-small cell lung cancer"-tx-1-"NON-SMALL CELL LUNG CANCER"-noun-0]	TX	0/26	
NONE_(HEALTHY_CONTROL)	MMI	3.75	Healthy Control	C2986479	[qlco]	["Healthy Control"-tx-1-"HEALTHY CONTROL"-noun-0]	TX	6/15	
NORMAL	MMI	5.18	Gait normal	C0231683	[fndg]	["Normal"-tx-1-"NORMAL"-adj-0]	TX	0/6	
NORMAL	MMI	5.18	Mean Percent of Normal	C2347086	[qnco]	["% Normal"-tx-1-"NORMAL"-adj-0]	TX	0/6	
NORMAL	MMI	5.18	Normal	C0205307	[qlco]	["NORMAL"-tx-1-"NORMAL"-adj-0]	TX	0/6	
NORMAL	MMI	5.18	Percent normal	C0439166	[qnco]	["% normal"-tx-1-"NORMAL"-adj-0]	TX	0/6	
NORMAL_BENIGN_SKIN_LESION	MMI	3.70	Skin appearance normal (finding)	C0558145	[fndg]	["Normal Skin"-tx-1-"NORMAL SKIN"-noun-0]	TX	0/6,14/4	
NORMAL_BENIGN_SKIN_LESION	MMI	3.68	Skin lesion	C0037284	[dsyn]	["SKIN LESION"-tx-1-"SKIN LESION"-noun-0]	TX	14/11	
NORMAL_BENIGN_SKIN_LESION	MMI	3.61	Lesion	C0221198	[fndg]	["Lesion"-tx-1-"LESION"-noun-0]	TX	19/6	
NORMAL_BENIGN_SKIN_LESION	MMI	3.61	Specimen Source Codes - Lesion	C1546698	[inpr]	["Lesion"-tx-1-"LESION"-noun-0]	TX	19/6	
NORMAL_BENIGN_SKIN_LESION	MMI	3.47	Benign	C0205183	[qlco]	["BENIGN"-tx-1-"BENIGN"-adj-0]	TX	7/6	
NORMAL_BENIGN_SKIN_LESION	MMI	3.47	Gait normal	C0231683	[fndg]	["Normal"-tx-1-"NORMAL"-adj-0]	TX	0/6	
NORMAL_BENIGN_SKIN_LESION	MMI	3.47	Mean Percent of Normal	C2347086	[qnco]	["% Normal"-tx-1-"NORMAL"-adj-0]	TX	0/6	
NORMAL_BENIGN_SKIN_LESION	MMI	3.47	Normal	C0205307	[qlco]	["NORMAL"-tx-1-"NORMAL"-adj-0]	TX	0/6	
NORMAL_BENIGN_SKIN_LESION	MMI	3.47	Percent normal	C0439166	[qnco]	["% normal"-tx-1-"NORMAL"-adj-0]	TX	0/6	
NORMAL_NON_SMOKERS	MMI	3.75	Non-smoker	C0337672	[fndg]	["non smokers"-tx-1-"NON SMOKERS"-noun-0]	TX	7/11	
NORMAL_NON_SMOKERS	MMI	3.48	Gait normal	C0231683	[fndg]	["Normal"-tx-1-"NORMAL"-adj-1]	TX	0/6	
NORMAL_NON_SMOKERS	MMI	3.48	Mean Percent of Normal	C2347086	[qnco]	["% Normal"-tx-1-"NORMAL"-adj-0]	TX	0/6	
NORMAL_NON_SMOKERS	MMI	3.48	Normal	C0205307	[qlco]	["NORMAL"-tx-1-"NORMAL"-adj-0]	TX	0/6	
NORMAL_NON_SMOKERS	MMI	3.48	Percent normal	C0439166	[qnco]	["% normal"-tx-1-"NORMAL"-adj-0]	TX	0/6	
NOT_APPLICABLE	MMI	5.18	Not Applicable	C1272460	[qlco]	["NOT APPLICABLE"-tx-1-"NOT APPLICABLE"-adj-0]	TX	0/14	
NOT_APPLICABLE	MMI	5.18	Package Type Not Applicable	C4049872	[ftcn]	["Not Applicable"-tx-1-"NOT APPLICABLE"-adj-0]	TX	0/14	
NOT_COLLECTED	MMI	3.68	Collected	C1516695	[idcn]	["Collected"-tx-1-"COLLECTED"-verb-0]	TX	4/9	
NOT_COLLECTED	MMI	3.68	Collection (action)	C1516698	[ftcn]	["Collected"-tx-1-"COLLECTED"-verb-0]	TX	4/9	
NOT_COLLECTED	MMI	3.68	Negation	C1518422	[ftcn]	["Not"-tx-1-"NOT"-adv-0]	TX	0/3	
NOT_REPORTED	MMI	3.68	Negation	C1518422	[ftcn]	["Not"-tx-1-"NOT"-adv-0]	TX	0/3	
NOT_REPORTED	MMI	3.68	Report (document)	C0684224	[inpr]	["Reported"-tx-1-"REPORTED"-verb-0]	TX	4/8	
NOT_REPORTED	MMI	3.68	Reporting	C0700287	[hlca]	["Reported"-tx-1-"REPORTED"-verb-0]	TX	4/8	
NO	MMI	17.80	Nitric Oxide	C0028128	[bacs,inch,phsu]	["NO"-tx-1-"NO"-noun-0]	TX	0/2	D01.339.387;D01.625.550.500;D01.625.700.500;D01.650.550.587.600
NO	MMI	5.18	Negation	C1518422	[ftcn]	["No"-tx-1-"NO"-noun-0]	TX	0/2	
NO	MMI	5.18	Nitric Oxide Measurement	C3810607	[lbpr]	["NO"-tx-1-"NO"-noun-0]	TX	0/2	
NO	MMI	5.18	No - yes/no indicator	C1549444	[idcn]	["No"-tx-1-"NO"-noun-0]	TX	0/2	
NO	MMI	5.18	no	C1298908	[idcn]	["NO"-tx-1-"NO"-noun-0]	TX	0/2	
NO_DISEASE	MMI	5.18	No Evidence of Coronary Artery Disease	C3275117	[fndg]	["NO DISEASE"-tx-1-"NO DISEASE"-noun-0]	TX	0/10	
NO_DISEASE	MMI	5.18	No disease	C0497153	[fndg]	["No disease"-tx-1-"NO DISEASE"-noun-0]	TX	0/10	
NO_KNOWN_CARDIAC_DISEASES	MMI	16.08	Nitric Oxide	C0028128	[bacs,inch,phsu]	["NO"-tx-1-"NO"-noun-0]	TX	0/2	D01.339.387;D01.625.550.500;D01.625.700.500;D01.650.550.587.600
NO_KNOWN_CARDIAC_DISEASES	MMI	6.83	Heart Diseases	C0018799	[dsyn]	["Cardiac Diseases"-tx-1-"CARDIAC DISEASES"-noun-1]	TX	9/16	C14.280
NO_KNOWN_CARDIAC_DISEASES	MMI	3.47	Known	C0205309	[qlco]	["Known"-tx-1-"KNOWN"-adj-0]	TX	3/5	
NO_KNOWN_CARDIAC_DISEASES	MMI	3.47	Negation	C1518422	[ftcn]	["No"-tx-1-"NO"-noun-0]	TX	0/2	
NO_KNOWN_CARDIAC_DISEASES	MMI	3.47	Nitric Oxide Measurement	C3810607	[lbpr]	["NO"-tx-1-"NO"-noun-0]	TX	0/2	
NO_KNOWN_CARDIAC_DISEASES	MMI	3.47	No - yes/no indicator	C1549444	[idcn]	["No"-tx-1-"NO"-noun-0]	TX	0/2	
NO_KNOWN_CARDIAC_DISEASES	MMI	3.47	no	C1298908	[idcn]	["NO"-tx-1-"NO"-noun-0]	TX	0/2	
OVARIAN_EPITHELIAL-SEROUS_CARCINOMA	MMI	13.27	Epithelial ovarian cancer	C0677886	[neop]	["ovarian epithelial carcinoma"-tx-1-"OVARIAN EPITHELIAL CARCINOMA"-noun-0]	TX	0/18,26/9	x.x.x.x
OVARIAN_EPITHELIAL-SEROUS_CARCINOMA	MMI	3.81	Ovarian Serous Adenocarcinoma	C1335177	[neop]	["Ovarian Serous Carcinoma"-tx-1-"OVARIAN SEROUS CARCINOMA"-noun-0]	TX	0/7,19/16	
OVARIAN_EPITHELIAL-SEROUS_CARCINOMA	MMI	3.47	Serous	C0440743	[qlco]	["Serous"-tx-1-"SEROUS"-adj-0]	TX	19/6	
OVARIAN_EPITHELIAL-SEROUS_CARCINOMA	MMI	3.47	epithelial	C0221908	[qlco]	["Epithelial"-tx-1-"EPITHELIAL"-adj-0]	TX	8/10	
OVARY_SEROUS_ADENOCARCINOMA	MMI	3.96	Ovarian Serous Adenocarcinoma	C1335177	[neop]	["Ovarian Serous Adenocarcinoma"-tx-1-"OVARY SEROUS ADENOCARCINOMA"-noun-0]	TX	0/27	
PANCREATIC_ADENOCARCINOMA'	MMI	5.18	Adenocarcinoma of pancreas	C0281361	[neop]	["Pancreatic Adenocarcinoma"-tx-1-"PANCREATIC ADENOCARCINOMA"-noun-0]	TX	0/25	
PAPILLARY_THYROID_CARCINOMA	MMI	14.64	Papillary thyroid carcinoma	C0238463	[neop]	["Papillary Thyroid Carcinoma"-tx-1-"PAPILLARY THYROID CARCINOMA"-noun-0]	TX	0/27	x.x.x.x
PARATYPHI_INFECTION	MMI	9.99	Communicable Diseases	C0009450	[dsyn]	["Infection, NOS"-tx-1-"INFECTION"-noun-0]	TX	10/9	C01.539.221
PATIENTS_WITH_BONE_MARROW_FAILURE_AND_CYTOGENETIC_ABNORMALITIES	MMI	12.93	Chromosome Aberrations	C0008625	[comd]	["Cytogenetic Abnormalities"-tx-1-"CYTOGENETIC ABNORMALITIES"-noun-0]	TX	38/25	C23.550.210;G05.365.590.175
PATIENTS_WITH_BONE_MARROW_FAILURE_AND_CYTOGENETIC_ABNORMALITIES	MMI	9.79	Pancytopenia	C0030312	[dsyn]	["Bone Marrow Failure"-tx-1-"BONE MARROW FAILURE"-noun-0]	TX	14/19	C15.378.700
PATIENTS_WITH_BONE_MARROW_FAILURE_AND_CYTOGENETIC_ABNORMALITIES	MMI	9.77	Congenital chromosomal disease	C0008626	[cgab,dsyn]	["Cytogenetic Abnormalities"-tx-1-"CYTOGENETIC ABNORMALITIES"-noun-0]	TX	38/25	C16.131.260;C16.320.180
PATIENTS_WITH_BONE_MARROW_FAILURE_AND_CYTOGENETIC_ABNORMALITIES	MMI	6.75	Patients	C0030705	[podg]	["Patients"-tx-1-"PATIENTS"-noun-0]	TX	0/8	M01.643
PATIENTS_WITH_BONE_MARROW_FAILURE_AND_CYTOGENETIC_ABNORMALITIES	MMI	3.48	Bone marrow hypocellularity	C1855710	[fndg]	["Bone marrow failure"-tx-1-"BONE MARROW FAILURE"-noun-0]	TX	14/19	
PITUITARY_GLAND_ADENOMA	MMI	27.26	Pituitary Adenoma	C0032000	[neop]	["Pituitary Gland Adenoma"-tx-1-"PITUITARY GLAND ADENOMA"-noun-0]	TX	0/23	C04.588.322.609;C04.588.614.250.195.885.500.600;C10.228.140.211.885.500.600;C10.228.140.617.477.600;C10.228.140.617.738.675;C10.551.240.250.700.500.500;C19.344.609;C19.700.734
POORLY_DIFFERENTIATED_SEROUS_OVARIAN_ADENOCARCINOMA	MMI	3.72	Ovarian Serous Adenocarcinoma	C1335177	[neop]	["Serous Ovarian adenocarcinoma"-tx-1-"SEROUS OVARIAN ADENOCARCINOMA"-noun-0]	TX	22/29	
POORLY_DIFFERENTIATED_SEROUS_OVARIAN_ADENOCARCINOMA	MMI	3.65	Poorly differentiated	C0205617	[qlco]	["Poorly differentiated"-tx-1-"POORLY DIFFERENTIATED"-verb-0]	TX	0/21	
RENAL_CELL_ADENOCARCINOMA	MMI	20.95	Renal Cell Carcinoma	C0007134	[neop]	["Adenocarcinoma, Renal Cell"-tx-1-"RENAL CELL ADENOCARCINOMA"-noun-0]	TX	0/25	C04.557.470.200.025.390;C04.588.945.947.535.160;C12.758.820.750.160;C12.777.419.473.160;C13.351.937.820.535.160;C13.351.968.419.473.160
SEMINOMA	MMI	17.80	Seminoma	C0036631	[neop]	["SEMINOMA"-tx-1-"SEMINOMA"-noun-0]	TX	0/8	C04.557.465.330.800
THYROID	MMI	11.49	Thyroid Gland	C0040132	[bpoc]	["Thyroid, NOS"-tx-1-"THYROID"-noun-0]	TX	0/7	A06.407.900
THYROID	MMI	5.18	THYROID DIAGNOSTIC RADIOPHARMACEUTICALS	C3540038	[irda]	["THYROID"-tx-1-"THYROID"-noun-0]	TX	0/7	
UROTHELIAL_BLADDER_CARCINOMA	MMI	5.18	Transitional cell carcinoma of bladder	C0279680	[neop]	["Urothelial Bladder carcinoma"-tx-1-"UROTHELIAL BLADDER CARCINOMA"-noun-0]	TX	0/28	
UVEAL_MELANOMA	MMI	14.64	Uveal melanoma	C0220633	[neop]	["MELANOMA, UVEAL"-tx-1-"UVEAL MELANOMA"-noun-0]	TX	0/14	x.x.x.x
WELL-DIFFERENTIATED_HEPATOCELLULAR_CARCINOMA	MMI	5.18	Well Differentiated Hepatocellular Carcinoma	C3273033	[neop]	["Well Differentiated Hepatocellular Carcinoma"-tx-1-"WELL-DIFFERENTIATED HEPATOCELLULAR CARCINOMA"-noun-0]	TX	0/44	
NON-CF  3
NON-CF	MMI	16.30	Congo	C0009738	[geoa]	["CF"-tx-1-"CF"-adj-0]	TX	4/2	Z01.058.290.100.140
NON-CF	MMI	3.68	CFTR wt Allele	C3811819	[gngm]	["CF"-tx-1-"CF"-adj-0]	TX	4/2	
NON-CF	MMI	3.68	Negation	C1518422	[ftcn]	["Non"-tx-1-"NON"-adj-0]	TX	0/3	
NON-DISEASED  1
NON-DISEASED	MMI	3.68	Negation	C1518422	[ftcn]	["Non"-tx-1-"NON"-adj-0]	TX	0/3	
NON-MALIGNANT_TISSUE  3
NON-MALIGNANT_TISSUE	MMI	3.63	Body tissue	C0040300	[tisu]	["TISSUE"-tx-1-"TISSUE"-noun-0]	TX	14/6	A10
NON-MALIGNANT_TISSUE	MMI	3.63	Tissue Specimen Code	C1547928	[inpr]	["Tissue"-tx-1-"TISSUE"-noun-0]	TX	14/6	
NON-MALIGNANT_TISSUE	MMI	3.53	Non-Malignant	C1518371	[qlco]	["Non-Malignant"-tx-1-"NON-MALIGNANT"-adj-0]	TX	0/13	
NONCANCER  0
NONE  1
NONE_(HEALTHY_CONTROL)	MMI	3.75	Healthy Control	C2986479	[qlco]	["Healthy Control"-tx-1-"HEALTHY CONTROL"-noun-0]	TX	6/15	
NONE_(HEALTHY_CONTROL)  1
NONE_(HEALTHY_CONTROL)	MMI	3.75	Healthy Control	C2986479	[qlco]	["Healthy Control"-tx-1-"HEALTHY CONTROL"-noun-0]	TX	6/15	
NOT_APPLICABLE  2
NOT_APPLICABLE	MMI	5.18	Not Applicable	C1272460	[qlco]	["NOT APPLICABLE"-tx-1-"NOT APPLICABLE"-adj-0]	TX	0/14	
NOT_APPLICABLE	MMI	5.18	Package Type Not Applicable	C4049872	[ftcn]	["Not Applicable"-tx-1-"NOT APPLICABLE"-adj-0]	TX	0/14	
NOT_COLLECTED  3
NOT_COLLECTED	MMI	3.68	Collected	C1516695	[idcn]	["Collected"-tx-1-"COLLECTED"-verb-0]	TX	4/9	
NOT_COLLECTED	MMI	3.68	Collection (action)	C1516698	[ftcn]	["Collected"-tx-1-"COLLECTED"-verb-0]	TX	4/9	
NOT_COLLECTED	MMI	3.68	Negation	C1518422	[ftcn]	["Not"-tx-1-"NOT"-adv-0]	TX	0/3	
NOT_REPORTED  3
NOT_REPORTED	MMI	3.68	Negation	C1518422	[ftcn]	["Not"-tx-1-"NOT"-adv-0]	TX	0/3	
NOT_REPORTED	MMI	3.68	Report (document)	C0684224	[inpr]	["Reported"-tx-1-"REPORTED"-verb-0]	TX	4/8	
NOT_REPORTED	MMI	3.68	Reporting	C0700287	[hlca]	["Reported"-tx-1-"REPORTED"-verb-0]	TX	4/8	
PANCREAS  4
PANCREAS	MMI	8.34	Pancreas	C0030274	[bpoc]	["PANCREAS"-tx-1-"PANCREAS"-noun-0]	TX	0/8	A03.734
PANCREAS	MMI	5.18	Entire pancreas	C1278931	[bpoc]	["Pancreas"-tx-1-"PANCREAS"-noun-0]	TX	0/8	
PANCREAS_CANCER	MMI	14.64	Pancreatic carcinoma	C0235974	[neop]	["Pancreas Cancer"-tx-1-"PANCREAS_CANCER"-noun-0]	TX	0/15	x.x.x.x
PANCREAS_CANCER	MMI	5.18	Malignant neoplasm of pancreas	C0346647	[neop]	["Cancer, Pancreas"-tx-1-"PANCREAS_CANCER"-noun-0]	TX	0/15	
PCA  0
PSORASIS  0
RRMS  1
RRMS	MMI	3.98	RNA Recognition Motif	C1522002	[aapp,bacs]	["RRM"-tx-1-"RRMS"-noun-0]	TX	0/4	
SALS  3
SALS	MMI	16.44	Sodium Chloride	C0037494	[bacs,inch,phsu]	["Salt"-tx-1-"SALS"-noun-0]	TX	0/4	D01.210.450.150.875;D01.857.650
SALS	MMI	13.28	Sodium Chloride, Dietary	C0206136	[food]	["Salt"-tx-1-"SALS"-noun-0]	TX	0/4	D01.857.650.705;D01.857.700.705
SALS	MMI	6.97	Salts	C0036140	[chvs]	["Salts"-tx-1-"SALS"-noun-0]	TX	0/4	D01.786
SBS  0
SCHIZO  0
SKML  0
STOMACH  4
STOMACH	MMI	14.64	Stomach	C0038351	[bpoc]	["STOMACH"-tx-1-"STOMACH"-noun-0]	TX	0/7	A03.556.875.875
STOMACH	MMI	5.18	Entire stomach	C1278920	[bpoc]	["Stomach"-tx-1-"STOMACH"-noun-0]	TX	0/7	
STOMACH	MMI	5.18	Gastric Tissue	C1517454	[tisu]	["STOMACH"-tx-1-"STOMACH"-noun-0]	TX	0/7	
STOMACH	MMI	5.18	Stomach structure	C3714551	[bpoc]	["Stomach"-tx-1-"STOMACH"-noun-0]	TX	0/7	
SYS  3
SYSTEMIC_ANAPHYLACTIC_SHOCK	MMI	13.22	anaphylaxis	C0002792	[patf]	["ANAPHYLACTIC SHOCK"-tx-1-"ANAPHYLACTIC SHOCK"-noun-0]	TX	9/18	C20.543.480.099
SYSTEMIC_ANAPHYLACTIC_SHOCK	MMI	3.48	Systemic	C0205373	[ftcn]	["Systemic"-tx-1-"SYSTEMIC"-adj-0]	TX	0/8	
SYS	MMI	5.18	SARS2 gene	C1425041	[gngm]	["SYS"-tx-1-"SYS"-noun-0]	TX	0/3	
SZD  0
THYROID  8
ANAPLASTIC_THYROID_CANCER	MMI	17.80	Anaplastic thyroid carcinoma	C0238461	[neop]	["Anaplastic Thyroid Cancer"-tx-1-"ANAPLASTIC THYROID CANCER"-noun-0]	TX	0/25	C04.557.470.200.725
PAPILLARY_THYROID_CARCINOMA	MMI	14.64	Papillary thyroid carcinoma	C0238463	[neop]	["Papillary Thyroid Carcinoma"-tx-1-"PAPILLARY THYROID CARCINOMA"-noun-0]	TX	0/27	x.x.x.x
THYROID	MMI	11.49	Thyroid Gland	C0040132	[bpoc]	["Thyroid, NOS"-tx-1-"THYROID"-noun-0]	TX	0/7	A06.407.900
THYROID	MMI	5.18	THYROID DIAGNOSTIC RADIOPHARMACEUTICALS	C3540038	[irda]	["THYROID"-tx-1-"THYROID"-noun-0]	TX	0/7	
THYROID_CANCER	MMI	5.18	Malignant neoplasm of thyroid	C0007115	[neop]	["-- Thyroid Cancer"-tx-1-"THYROID_CANCER"-noun-0]	TX	0/14	
THYROID_CANCER	MMI	5.18	NCI CTEP SDC Thyroid Cancer Sub-Category Terminology	C3541337	[inpr]	["Thyroid Cancer"-tx-1-"THYROID_CANCER"-noun-0]	TX	0/14	
THYROID_CANCER	MMI	5.18	Papillary Thyroid Carcinoma Pathway	C2984307	[cnce]	["Thyroid cancer"-tx-1-"THYROID_CANCER"-noun-0]	TX	0/14	
THYROID_CANCER	MMI	5.18	Thyroid carcinoma	C0549473	[neop]	["Cancer, Thyroid"-tx-1-"THYROID_CANCER"-noun-0]	TX	0/14	
UNAFFECTED  1
UNAFFECTED	MMI	5.18	Unaffected	C2986417	[cnce]	["Unaffected"-tx-1-"UNAFFECTED"-adj-0]	TX	0/10	
WILD-TYPE_CONTROL  6
WILD-TYPE_CONTROL	MMI	3.63	Control function	C2587213	[ftcn]	["Control"-tx-1-"CONTROL"-noun-0]	TX	10/7	
WILD-TYPE_CONTROL	MMI	3.63	Scientific Control	C1882979	[cnce]	["Control"-tx-1-"CONTROL"-noun-0]	TX	10/7	
WILD-TYPE_CONTROL	MMI	3.63	True Control Status	C3274648	[qlco]	["Control"-tx-1-"CONTROL"-noun-0]	TX	10/7	
WILD-TYPE_CONTROL	MMI	3.63	control aspects	C0243148	[qlco]	["control"-tx-1-"CONTROL"-noun-0]	TX	10/7	
WILD-TYPE_CONTROL	MMI	3.63	control substance	C1550141	[sbst]	["Control"-tx-1-"CONTROL"-noun-0]	TX	10/7	
WILD-TYPE_CONTROL	MMI	3.53	Wild Type	C1883559	[gngm]	["Wildtype"-tx-1-"WILD-TYPE"-adj-0]	TX	0/9	
